,X,biomarker_ID,main_Xref,assessed_biomarker_entity,biomarker_status,best_biomarker_type,specimen_type,loinc_code,condition_name,assessed_entity_type,evidence_source,notes,DOID,Uberon ID,ID,test,name,change,system
0,0,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1,1,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
2,2,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
3,3,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (I242T,M244V,K247R,L248V,G250E,G250R,Q252R,Q252H,Y253F,Y253H,E255K,E255V,M237V,E258D,W261L,L273M,E275K,E275Q,D276G,T277A,E279K,V280A,V289A,V289I,E292V,E292Q,I293V,L298V,V299L,F311L,F311I,T315I,F317L,F317V,F317I,F317C,Y320C,L324Q,Y342H,M343T,A344V,A350V,M351T,E355D,E355G,E355A,F359V,F359I,F359C,F359L,D363Y,L364I,A365V,A366G,L370P,V371A,E373K,V379I,A380T,F382L,L384M,L387M,L387F,L387V,M388L,Y393C,H396P,H396R,H396A,A397P,S417F,S417Y,I418S,I418V,A433T,S438C,E450K,E450G,E450A,E450V,E453K,E453G,E453A,E453V,E459K,E459G,E459A,E459V,M472I,P480L,F486S,E507G)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","I242T,M244V,K247R,L248V,G250E,G250R,Q252R,Q252H,Y253F,Y253H,E255K,E255V,M237V,E258D,W261L,L273M,E275K,E275Q,D276G,T277A,E279K,V280A,V289A,V289I,E292V,E292Q,I293V,L298V,V299L,F311L,F311I,T315I,F317L,F317V,F317I,F317C,Y320C,L324Q,Y342H,M343T,A344V,A350V,M351T,E355D,E355G,E355A,F359V,F359I,F359C,F359L,D363Y,L364I,A365V,A366G,L370P,V371A,E373K,V379I,A380T,F382L,L384M,L387M,L387F,L387V,M388L,Y393C,H396P,H396R,H396A,A397P,S417F,S417Y,I418S,I418V,A433T,S438C,E450K,E450G,E450A,E450V,E453K,E453G,E453A,E453V,E459K,E459G,E459A,E459V,M472I,P480L,F486S,E507G",Bld/Bone mar
4,4,,dbSNP:rs2300149,rs2300149 mutation in polybromo 1 (PBRM1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163939/HP_0001787,UPKB:Q86U86 (PBRM1 deletion)|GRCh38,,,ENSG00000163939,,polybromo 1,,
5,5,,dbSNP:rs62236881,rs62236881 mutation in checkpoint kinase 2 (CHEK2),presence of,risk_biomarker,blood (UN:0000178),72518-4,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000183765/HP_0001787,UPKB:O96017 (CHEK2 oncogenic mutation)|GRCh38,2526.0,,ENSG00000183765,,checkpoint kinase 2,,Bld/Tiss
6,6,,dbSNP:rs2184540,rs2184540 mutation in spleen associated tyrosine kinase (SYK),presence of,risk_biomarker,,,chronic lymphocytic leukemia (DOID:1040),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165025/HP_0001787,UPKB:P43405 (SYK amplification)|GRCh38,1040.0,,ENSG00000165025,,spleen associated tyrosine kinase,,
7,7,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,4001.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
8,8,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (K753E) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,K753E) (inframe_insertion:775-881,Tiss
9,9,,dbSNP:rs76939542,rs76939542 mutation in aurora kinase A (AURKA),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000087586/HP_0001787,UPKB:O14965 (AURKA amplification)|GRCh38,2526.0,,ENSG00000087586,,aurora kinase A,,
10,10,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,UPKB:Q96SW2 (CRBN oncogenic mutation)|GRCh38,9538.0,,ENSG00000113851,,cereblon,,
11,11,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,"UPKB:Q9UM73 (R1275Q,G1128A,I1171N,R1192P,F1245C)|GRCh38 ",,,ENSG00000171094,,ALK receptor tyrosine kinase,"R1275Q,G1128A,I1171N,R1192P,F1245C",Bld/Tiss
12,12,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
13,13,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
14,14,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,myelodisplasic syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
15,15,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
16,16,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (G469A)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",G469A,Bld/Tiss
17,17,,dbSNP:rs4402166,rs4402166 mutation in AT-rich interaction domain 1A (ARID1A),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117713/HP_0001787,UPKB:O14497 (ARID1A oncogenic mutation)|GRCh38,,,ENSG00000117713,,AT-rich interaction domain 1A,,
18,18,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 amplification + RB1 expression)|GRCh38,3382.0,,ENSG00000135446,,cyclin dependent kinase 4,,
19,19,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (E17K)|GRCh38 ,,,ENSG00000142208,,AKT serine/threonine kinase 1,E17K,Bld/Tiss
20,20,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,4607.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
21,21,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,"UPKB:P16234 (552-596,631-668,814-854)|GRCh38 ",,,ENSG00000134853,,platelet derived growth factor receptor alpha,"552-596,631-668,814-854",Bld/Tiss
22,22,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
23,23,,dbSNP:rs6778355,rs6778355 mutation in melanocyte inducing transcription factor (MITF),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000187098/HP_0001787,UPKB:O75030 (MITF amplification)|GRCh38,8923.0,,ENSG00000187098,,melanocyte inducing transcription factor,,
24,24,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
25,25,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,2526.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
26,26,,dbSNP:rs6434928,rs6434928 mutation in splicing factor 3b subunit 1 (SF3B1),presence of,risk_biomarker,blood (UN:0000178),99129-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000115524/HP_0001787,"UPKB:O75533 (K700E,K666N)|GRCh38 ",,,ENSG00000115524,,splicing factor 3b subunit 1,"K700E,K666N",Bld/Tiss
27,27,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (MET amplification + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
28,28,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,UPKB:Q9UQQ2 (S185C)|GRCh38 ,9952.0,,ENSG00000111252,,SH2B adaptor protein 3,S185C,
29,29,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (F877L)|GRCh38 ,2526.0,,ENSG00000169083,,androgen receptor,F877L,Bld/Tiss
30,30,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (F1174L)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,F1174L,Bld/Tiss
31,31,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (NF2),presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (NF2 oncogenic mutation + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000146648,,epidermal growth factor receptor,,Amnio fld
32,32,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
33,33,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,"UPKB:P07949 (618,620,634,768,791,891,918,C634W,M918T)|GRCh38 ",,,ENSG00000165731,,ret proto-oncogene,"618,620,634,768,791,891,918,C634W,M918T",Bld/Tiss
34,34,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,4001.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
35,35,,dbSNP:rs2300149,rs2300149 mutation in polybromo 1 (PBRM1),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163939/HP_0001787,UPKB:Q86U86 (PBRM1 undexpression)|GRCh38,4451.0,,ENSG00000163939,,polybromo 1,,
36,36,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4001.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
37,37,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,lymphangioleiomyomatosis (DOID:3319),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (TSC2 deletion)|GRCh38,3319.0,,ENSG00000103197,,TSC complex subunit 2,,Bld/Tiss
38,38,,dbSNP:rs3879293,rs3879293 mutation in MDM2 proto-oncogene (MDM2),presence of,risk_biomarker,tissue (UN:0000479),93805-0,male germ cell tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135679/HP_0001787,UPKB:Q00987 (MDM2 amplification)|GRCh38,,,ENSG00000135679,,MDM2 proto-oncogene,,Tiss
39,39,,dbSNP:rs2800278,rs2800278 mutation in discoidin domain receptor tyrosine kinase 2 (DDR2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162733/HP_0001787,UPKB:Q16832 (S768R)|GRCh38 ,,,ENSG00000162733,,discoidin domain receptor tyrosine kinase 2,S768R,
40,40,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 deletion)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
41,41,,dbSNP:rs200368423,rs200368423 mutation in notch receptor 2 (NOTCH2),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134250/HP_0001787,UPKB:Q04721 (missense in TAD or truncating in Cterm-PEST domain)|GRCh38 ,9119.0,,ENSG00000134250,,notch receptor 2,missense in TAD or truncating in Cterm-PEST domain,
42,42,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
43,43,,dbSNP:rs357564,rs357564 mutation in patched 1 (PTCH1),presence of,risk_biomarker,,,basal cell carcinoma (DOID:2513),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000185920/HP_0001787,UPKB:Q13635 (PTCH1 oncogenic mutation)|GRCh38,2513.0,,ENSG00000185920,,patched 1,,
44,44,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT biallelic inactivation)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
45,45,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
46,46,,dbSNP:rs1720727,rs1720727 mutation in beta-2-microglobulin (B2M),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000166710/HP_0001787,UPKB:P61769 (B2M oncogenic mutation)|GRCh38,8923.0,,ENSG00000166710,,beta-2-microglobulin,,
47,47,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
48,48,,dbSNP:rs350912,rs350912 mutation in mitogen-activated protein kinase kinase 2 (MAP2K2),presence of,risk_biomarker,blood (UN:0000178),60496-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000126934/HP_0001787,"UPKB:P36507 (V35M,L46F,N126D,C125S)|GRCh38 ",8923.0,,ENSG00000126934,,mitogen-activated protein kinase kinase 2,"V35M,L46F,N126D,C125S",Bld/Tiss
49,49,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
50,50,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
51,51,,dbSNP:rs1558001,rs1558001 mutation in hepatocyte growth factor (HGF),presence of,risk_biomarker,,,urinary tract carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000019991/HP_0001787,UPKB:P14210 (HGF overexpression)|GRCh38,,,ENSG00000019991,,hepatocyte growth factor,,
52,52,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
53,53,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
54,54,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (MET amplification + EGFR oncogenic mutation)|GRCh38,3910.0,,ENSG00000146648,,epidermal growth factor receptor,,Bld/Tiss
55,55,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4001.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
56,56,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R,T790M) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R,T790M) (inframe_insertion:729-761",Bld/Tiss
57,57,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,50861.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
58,58,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,9119.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
59,59,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
60,60,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
61,61,,dbSNP:rs530311131,rs530311131 mutation in von Hippel-Lindau tumor suppressor (VHL),presence of,risk_biomarker,blood (UN:0000178),34502-5,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134086/HP_0001787,UPKB:P40337 (VHL oncogenic mutation)|GRCh38,4451.0,,ENSG00000134086,,von Hippel-Lindau tumor suppressor,,Bld/Tiss
62,62,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600D,V600K,V600M,V600G,V600R)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600D,V600K,V600M,V600G,V600R",Bld/Tiss
63,63,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
64,64,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA amplification)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
65,65,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
66,66,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (RAD50),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (L1237F)|GRCh38 ,,,ENSG00000149311,,ATM serine/threonine kinase,L1237F,
67,67,,dbSNP:rs9332739,rs9332739 mutation in solute carrier family 44 member 4 (SLC44A4),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000204385/HP_0001787,UPKB:Q53GD3 (SLC44A4 overexpression)|GRCh38,2526.0,,ENSG00000204385,,solute carrier family 44 member 4,,
68,68,,dbSNP:rs12667978,"rs12667978 mutation in smoothened, frizzled class receptor (SMO)",presence of,risk_biomarker,,,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000128602/HP_0001787,UPKB:Q99835 (D473H)|GRCh38 ,50902.0,,ENSG00000128602,,"smoothened, frizzled class receptor",D473H,
69,69,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
70,70,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,4607.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
71,71,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
72,72,,dbSNP:rs1558001,rs1558001 mutation in hepatocyte growth factor (HGF),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000019991/HP_0001787,UPKB:P14210 (HGF amplification + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000019991,,hepatocyte growth factor,,
73,73,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
74,74,,dbSNP:rs2546110,rs2546110 mutation in APC regulator of WNT signaling pathway (APC),presence of,risk_biomarker,blood (UN:0000178),20990-8,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134982/HP_0001787,UPKB:P25054 (APC oncogenic mutation)|GRCh38,50861.0,,ENSG00000134982,,APC regulator of WNT signaling pathway,,Bld/Tiss
75,75,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
76,76,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET fusion)|GRCh38,3910.0,,ENSG00000165731,,ret proto-oncogene,,Bld/Tiss
77,77,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
78,78,,dbSNP:rs201233223,rs201233223 mutation in SUZ12 polycomb repressive complex 2 subunit (SUZ12),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178691/HP_0001787,UPKB:Q15022 (SUZ12 deletion)|GRCh38,,,ENSG00000178691,,SUZ12 polycomb repressive complex 2 subunit,,
79,79,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD biallelic inactivation)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
80,80,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
81,81,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (ROS1 fusion)|GRCh38,3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",,
82,82,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (I843)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,I843,Bld/Tiss
83,83,,dbSNP:rs62505473,rs62505473 mutation in fibroblast growth factor receptor 1 (FGFR1),presence of,risk_biomarker,blood (UN:0000178),42785-6,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000077782/HP_0001787,UPKB:P11362 (FGFR1 amplification)|GRCh38,11934.0,,ENSG00000077782,,fibroblast growth factor receptor 1,,Bld/Tiss
84,84,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (G12C)|GRCh38 ,,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",G12C,Bld/Tiss
85,85,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM deletion)|GRCh38,60058.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
86,86,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
87,87,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
88,88,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,"UPKB:P16234 (P577S,R841K,H845Y,G853D)|GRCh38 ",8923.0,,ENSG00000134853,,platelet derived growth factor receptor alpha,"P577S,R841K,H845Y,G853D",Bld/Tiss
89,89,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
90,90,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,UPKB:P21802 (FGFR2 fusion)|GRCh38,50861.0,,ENSG00000066468,,fibroblast growth factor receptor 2,,Bld/Tiss
91,91,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (P124L,K57N,C121S)|GRCh38 ",8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"P124L,K57N,C121S",Bld/Tiss
92,92,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,"UPKB:Q12882 (I560S,D949V)|GRCh38 ",,,ENSG00000188641,,dihydropyrimidine dehydrogenase,"I560S,D949V",Bld/Tiss
93,93,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
94,94,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
95,95,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
96,96,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,4007.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
97,97,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
98,98,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
99,99,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (P262H,G284R,Q809R)|GRCh38 ",,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"P262H,G284R,Q809R",
100,100,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK amplification)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
101,101,,dbSNP:rs4148325,rs4148325 mutation in UDP glucuronosyltransferase family 1 member A1 (UGT1A1),presence of,risk_biomarker,blood (UN:0000178),34509-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000241635/HP_0001787,UPKB:P22309 (UGT1A1 biallelic inactivation)|GRCh38,,,ENSG00000241635,,UDP glucuronosyltransferase family 1 member A1,,Bld/Tiss
102,102,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
103,103,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 oncogenic mutation)|GRCh38,,,ENSG00000163930,,BRCA1 associated protein 1,,
104,104,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
105,105,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3-ITD),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (FLT3-ITD)|GRCh38,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,,
106,106,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
107,107,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
108,108,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,4001.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
109,109,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (C121S)|GRCh38 ,8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,C121S,Bld/Tiss
110,110,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA overexpression)|GRCh38,4451.0,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
111,111,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
112,112,,dbSNP:rs9825207,rs9825207 mutation in ATR serine/threonine kinase (ATR),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175054/HP_0001787,UPKB:Q13535 (ATR deletion)|GRCh38,4001.0,,ENSG00000175054,,ATR serine/threonine kinase,,
113,113,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
114,114,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,"UPKB:Q9UM73 (L1196M,L1152R,C1156Y,F1174L,G1202R,S1206Y,G1269A,I1171T)|GRCh38 ",3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,"L1196M,L1152R,C1156Y,F1174L,G1202R,S1206Y,G1269A,I1171T",Bld/Tiss
115,115,,dbSNP:rs72922276,rs72922276 mutation in Janus kinase 1 (JAK1),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162434/HP_0001787,UPKB:P23458 (JAK1 oncogenic mutation)|GRCh38,8923.0,,ENSG00000162434,,Janus kinase 1,,
116,116,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (K57T)|GRCh38 ,50861.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,K57T,Bld/Tiss
117,117,,dbSNP:rs6511720,"rs6511720 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4)",presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000127616/HP_0001787,UPKB:P51532 (SMARCA4 oncogenic mutation)|GRCh38,4001.0,,ENSG00000127616,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",,
118,118,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
119,119,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A oncogenic mutation)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
120,120,,dbSNP:rs191425998,rs191425998 mutation in F-box and WD repeat domain containing 7 (FBXW7),presence of,risk_biomarker,blood (UN:0000178),100028-0,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109670/HP_0001787,UPKB:Q969H0 (FBXW7 oncogenic mutation)|GRCh38,9952.0,,ENSG00000109670,,F-box and WD repeat domain containing 7,,Bld/Tiss
121,121,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,2526.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
122,122,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 oncogenic mutation)|GRCh38,60058.0,,ENSG00000135446,,cyclin dependent kinase 4,,
123,123,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 amplification)|GRCh38,60058.0,,ENSG00000135446,,cyclin dependent kinase 4,,
124,124,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
125,125,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (Q1178*)|GRCh38 ,,,ENSG00000103197,,TSC complex subunit 2,Q1178*,Bld/Tiss
126,126,,dbSNP:rs62104483,rs62104483 mutation in cyclin E1 (CCNE1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105173/HP_0001787,UPKB:P24864 (CCNE1 amplification)|GRCh38,,,ENSG00000105173,,cyclin E1,,
127,127,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
128,128,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,"UPKB:P08922 (S1986Y,S1986F)|GRCh38 ",3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase","S1986Y,S1986F",
129,129,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
130,130,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
131,131,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (MAP2K1 oncogenic mutation)|GRCh38,50861.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,,Bld/Tiss
132,132,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (P124)|GRCh38 ,8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,P124,Bld/Tiss
133,133,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET mutation in exon 16-19)|GRCh38,4451.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
134,134,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,2871.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
135,135,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 deletion)|GRCh38,,,ENSG00000163930,,BRCA1 associated protein 1,,
136,136,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
137,137,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,3382.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
138,138,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (V299L)|GRCh38 ,,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",V299L,Bld/Bone mar
139,139,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (I99T,L115,G128D,F129L,V211D,L215P,I103N,K104N,I111N,H119P,E120D,F133L,P124,D67N)|GRCh38 ",,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"I99T,L115,G128D,F129L,V211D,L215P,I103N,K104N,I111N,H119P,E120D,F133L,P124,D67N",Bld/Tiss
140,140,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (G2032R)|GRCh38 ,3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",G2032R,
141,141,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3-ITD),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (FLT3-ITD)|GRCh38,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,,
142,142,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3458.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
143,143,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (PIK3CB oncogenic mutation)|GRCh38,5520.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",,
144,144,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (E17K)|GRCh38 ,,,ENSG00000142208,,AKT serine/threonine kinase 1,E17K,Bld/Tiss
145,145,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 overexpression)|GRCh38,4007.0,,ENSG00000120217,,CD274 molecule,,
146,146,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT splice acceptor variant)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
147,147,,dbSNP:rs4402166,rs4402166 mutation in AT-rich interaction domain 1A (ARID1A),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117713/HP_0001787,UPKB:O14497 (ARID1A oncogenic mutation + ANXA1 overexpression)|GRCh38,3458.0,,ENSG00000117713,,AT-rich interaction domain 1A,,
148,148,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (P546S) (inframe_insertion:729-761)|GRCh38 ,11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,P546S) (inframe_insertion:729-761,Bld/Tiss
149,149,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 biallelic inactivation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
150,150,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761)|GRCh38 ",3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761",Bld/Tiss
151,151,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
152,152,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (PTEN)",presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (PTEN oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
153,153,,dbSNP:rs527697748,rs527697748 mutation in marker of proliferation Ki-67 (MKI67),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148773/HP_0001787,UPKB:P46013 (MKI67 overexpression)|GRCh38,4451.0,,ENSG00000148773,,marker of proliferation Ki-67,,
154,154,,dbSNP:rs4148325,rs4148325 mutation in UDP glucuronosyltransferase family 1 member A1 (UGT1A1),presence of,risk_biomarker,blood (UN:0000178),34509-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000241635/HP_0001787,"UPKB:P22309 (G71R,P229Q)|GRCh38 ",,,ENSG00000241635,,UDP glucuronosyltransferase family 1 member A1,"G71R,P229Q",Bld/Tiss
155,155,,dbSNP:rs744617,rs744617 mutation in PML nuclear body scaffold (PML-RARA),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140464/HP_0001787,UPKB:P29590 (PML-RARA fusion)|GRCh38,9119.0,,ENSG00000140464,,PML nuclear body scaffold,,
156,156,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761",Bld/Tiss
157,157,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,UPKB:P04629 (G595R)|GRCh38 ,,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,G595R,Tiss
158,158,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
159,159,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
160,160,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
161,161,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (K601R,L597R,V600R)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","K601R,L597R,V600R",Bld/Tiss
162,162,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (G469A)|GRCh38 ,5520.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",G469A,Bld/Tiss
163,163,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,50861.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
164,164,,dbSNP:rs2800278,rs2800278 mutation in discoidin domain receptor tyrosine kinase 2 (DDR2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162733/HP_0001787,"UPKB:Q16832 (I638F,L239R,G253C,G774V,L63V,G505S)|GRCh38 ",,,ENSG00000162733,,discoidin domain receptor tyrosine kinase 2,"I638F,L239R,G253C,G774V,L63V,G505S",
165,165,,dbSNP:rs987106,rs987106 mutation in interleukin 7 receptor (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168685/HP_0001787,"UPKB:P16871 (237-255),inframe deletion (237-255)|GRCh38 ",9952.0,,ENSG00000168685,,interleukin 7 receptor,"237-255),inframe deletion (237-255",
166,166,,dbSNP:rs350912,rs350912 mutation in mitogen-activated protein kinase kinase 2 (MAP2K2),presence of,risk_biomarker,blood (UN:0000178),60496-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000126934/HP_0001787,UPKB:P36507 (Q60P)|GRCh38 ,8923.0,,ENSG00000126934,,mitogen-activated protein kinase kinase 2,Q60P,Bld/Tiss
167,167,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
168,168,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
169,169,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3908.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
170,170,,dbSNP:rs107155,rs107155 mutation in G protein subunit alpha 11 (GNA11),presence of,risk_biomarker,blood (UN:0000178),100020-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000088256/HP_0001787,"UPKB:P29992 (Q209L,Q209P)|GRCh38 ",8923.0,,ENSG00000088256,,G protein subunit alpha 11,"Q209L,Q209P",Bld/Tiss
171,171,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
172,172,,dbSNP:rs35347644,rs35347644 mutation in potassium inwardly rectifying channel subfamily J member 5 (KCNJ5),presence of,risk_biomarker,,,adrenal adenoma (DOID:656),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120457/HP_0001787,UPKB:P48544 (L168R)|GRCh38 ,656.0,,ENSG00000120457,,potassium inwardly rectifying channel subfamily J member 5,L168R,
173,173,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (E545*)|GRCh38 ,8923.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",E545*,Bld/Tiss
174,174,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (G309E,S310F,S310Y,C311R,E321G,C334S) (inframe_insertion:775-881)|GRCh38 ",,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"G309E,S310F,S310Y,C311R,E321G,C334S) (inframe_insertion:775-881",Tiss
175,175,,dbSNP:rs2300149,rs2300149 mutation in polybromo 1 (PBRM1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163939/HP_0001787,UPKB:Q86U86 (PBRM1 oncogenic mutation)|GRCh38,,,ENSG00000163939,,polybromo 1,,
176,176,,dbSNP:Q06187,Q06187 mutation in Bruton tyrosine kinase (BTK),presence of,risk_biomarker,blood (UN:0000178),35295-5,mantle cell lymphoma (DOID:0050746),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000010671/HP_0001787,UPKB:Q06187 (C481)|GRCh38 ,50746.0,,ENSG00000010671,,Bruton tyrosine kinase,C481,Bld/Tiss
177,177,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
178,178,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 oncogenic mutation)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
179,179,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
180,180,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
181,181,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (V659E,S310F) (inframe_insertion:775-881)|GRCh38 ",3905.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"V659E,S310F) (inframe_insertion:775-881",Tiss
182,182,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (P262H,G284R)|GRCh38 ",,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"P262H,G284R",
183,183,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
184,184,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
185,185,,dbSNP:rs1050828,rs1050828 mutation in glucose-6-phosphate dehydrogenase (G6PD),presence of,risk_biomarker,blood (UN:0000178),21680-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000160211/HP_0001787,UPKB:P11413 (G6PD biallelic inactivation)|GRCh38,,,ENSG00000160211,,glucose-6-phosphate dehydrogenase,,Bld/Tiss
186,186,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
187,187,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,UPKB:P21802 (V565I)|GRCh38 ,2871.0,,ENSG00000066468,,fibroblast growth factor receptor 2,V565I,Bld/Tiss
188,188,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761)|GRCh38 ",3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761",Bld/Tiss
189,189,,dbSNP:rs11867902,rs11867902 mutation in DNA topoisomerase II alpha (TOP2A),presence of,risk_biomarker,tissue (UN:0000479),63068-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000131747/HP_0001787,UPKB:P11388 (TOP2A amplification)|GRCh38,3458.0,,ENSG00000131747,,DNA topoisomerase II alpha,,Tiss
190,190,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (F691)|GRCh38 ,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,F691,Bld/Tiss
191,191,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT amplification)|GRCh38,8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
192,192,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (IDH1 oncogenic mutation)|GRCh38,,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,,Bld/Tiss
193,193,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
194,194,,dbSNP:rs265548,rs265548 mutation in Janus kinase 3 (JAK3),presence of,risk_biomarker,blood (UN:0000178),47963-4,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105639/HP_0001787,"UPKB:P52333 (A572V,A573V)|GRCh38 ",60058.0,,ENSG00000105639,,Janus kinase 3,"A572V,A573V",Bld/Tiss
195,195,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
196,196,,dbSNP:rs4417855,rs4417855 mutation in BCL6 transcription repressor (BCL6),presence of,risk_biomarker,blood (UN:0000178),21746-3,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113916/HP_0001787,UPKB:P41182 (BCL6 overexpression)|GRCh38,60058.0,,ENSG00000113916,,BCL6 transcription repressor,,Bld/Tiss
197,197,,dbSNP:rs2842198,"rs2842198 mutation in MPL proto-oncogene, thrombopoietin receptor (MPL)",presence of,risk_biomarker,blood (UN:0000178),56141-5,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117400/HP_0001787,UPKB:P40238 (W515F)|GRCh38 ,,,ENSG00000117400,,"MPL proto-oncogene, thrombopoietin receptor",W515F,Bld/Tiss
198,198,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
199,199,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
200,200,,dbSNP:rs12667978,"rs12667978 mutation in smoothened, frizzled class receptor (SMO)",presence of,risk_biomarker,,,basal cell carcinoma (DOID:2513),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000128602/HP_0001787,"UPKB:Q99835 (D473H,D473G,W535L,L412F,W281C,Q477E,G497W)|GRCh38 ",2513.0,,ENSG00000128602,,"smoothened, frizzled class receptor","D473H,D473G,W535L,L412F,W281C,Q477E,G497W",
201,201,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
202,202,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
203,203,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
204,204,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
205,205,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,neuroblastoma (DOID:769),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,769.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
206,206,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (V299L)|GRCh38 ,,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",V299L,Bld/Bone mar
207,207,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
208,208,,dbSNP:rs191425998,rs191425998 mutation in F-box and WD repeat domain containing 7 (FBXW7),presence of,risk_biomarker,blood (UN:0000178),100028-0,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109670/HP_0001787,UPKB:Q969H0 (FBXW7 deletion)|GRCh38,50861.0,,ENSG00000109670,,F-box and WD repeat domain containing 7,,Bld/Tiss
209,209,,dbSNP:rs7163762,rs7163762 mutation in isocitrate dehydrogenase (NADP(+)) 2 (IDH2),presence of,risk_biomarker,blood (UN:0000178),100023-1,hematologic malignancies,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000182054/HP_0001787,"UPKB:P48735 (R140K,R172K)|GRCh38 ",,,ENSG00000182054,,isocitrate dehydrogenase (NADP(+)) 2,"R140K,R172K",Bld/Tiss
210,210,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
211,211,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (S492R) (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,S492R) (inframe_insertion:729-761,Bld/Tiss
212,212,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,anaplastic oligodendroglioma (DOID:7154),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (K1771R)|GRCh38 ,7154.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,K1771R,
213,213,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
214,214,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
215,215,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
216,216,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM deletion)|GRCh38,5517.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
217,217,,dbSNP:rs56335522,rs56335522 mutation in erb-b2 receptor tyrosine kinase 4 (ERBB4),presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178568/HP_0001787,UPKB:Q15303 (ERBB4 fusion)|GRCh38,3910.0,,ENSG00000178568,,erb-b2 receptor tyrosine kinase 4,,
218,218,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (L1198F)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,L1198F,Bld/Tiss
219,219,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 deletion)|GRCh38,4001.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
220,220,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,4001.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
221,221,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
222,222,,dbSNP:rs34523089,rs34523089 mutation in ring finger protein 43 (RNF43),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000108375/HP_0001787,UPKB:Q68DV7 (RNF43 oncogenic mutation)|GRCh38,50861.0,,ENSG00000108375,,ring finger protein 43,,
223,223,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,2526.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
224,224,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
225,225,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
226,226,,dbSNP:rs9825207,rs9825207 mutation in ATR serine/threonine kinase (ATR),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175054/HP_0001787,UPKB:Q13535 (ATR oncogenic mutation)|GRCh38,4001.0,,ENSG00000175054,,ATR serine/threonine kinase,,
227,227,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
228,228,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,5520.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
229,229,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (T670I)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",T670I,Bld/Tiss
230,230,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
231,231,,dbSNP:rs75495843,rs75495843 mutation in MYD88 innate immune signal transduction adaptor (MYD88),presence of,risk_biomarker,blood (UN:0000178),82140-5,waldenstroem macroglobulinemia,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000172936/HP_0001787,UPKB:Q99836 (L265P)|GRCh38 ,,,ENSG00000172936,,MYD88 innate immune signal transduction adaptor,L265P,Bld/Tiss
232,232,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (Q56P,P124S,P124L;C121S)|GRCh38 ",8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"Q56P,P124S,P124L;C121S",Bld/Tiss
233,233,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
234,234,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
235,235,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
236,236,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
237,237,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3908.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
238,238,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (R132)|GRCh38 ,4607.0,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,R132,Bld/Tiss
239,239,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA fusion)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
240,240,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
241,241,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,3905.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
242,242,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 overexpression)|GRCh38,,,ENSG00000120217,,CD274 molecule,,
243,243,,dbSNP:rs530311131,rs530311131 mutation in von Hippel-Lindau tumor suppressor (VHL),presence of,risk_biomarker,blood (UN:0000178),34502-5,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134086/HP_0001787,UPKB:P40337 (VHL oncogenic mutation)|GRCh38,4451.0,,ENSG00000134086,,von Hippel-Lindau tumor suppressor,,Bld/Tiss
244,244,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
245,245,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
246,246,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
247,247,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
248,248,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,5520.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
249,249,,dbSNP:rs4899037,rs4899037 mutation in protein kinase C eta (PRKCH),presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000027075/HP_0001787,UPKB:P24723 (PRKCH amplification + ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000027075,,protein kinase C eta,,
250,250,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
251,251,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (1151T)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,1151T,Bld/Tiss
252,252,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (V299L,T315A,F317L,F317V,F317I,F317C)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","V299L,T315A,F317L,F317V,F317I,F317C",Bld/Bone mar
253,253,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
254,254,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
255,255,,dbSNP:rs2584124,rs2584124 mutation in neurotrophic receptor tyrosine kinase 3 (NTRK3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140538/HP_0001787,UPKB:Q16288 (NTRK3 fusion)|GRCh38,3458.0,,ENSG00000140538,,neurotrophic receptor tyrosine kinase 3,,
256,256,,dbSNP:rs9813107,rs9813107 mutation in catenin beta 1 (CTNNB1),presence of,risk_biomarker,blood (UN:0000178),21659-8,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168036/HP_0001787,"UPKB:P35222 (H36Y,S37C,S37Y,D32V)|GRCh38 ",2871.0,,ENSG00000168036,,catenin beta 1,"H36Y,S37C,S37Y,D32V",Bld/Tiss
257,257,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (T315A,F317L,F317V,F317I,F317C,V299L)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","T315A,F317L,F317V,F317I,F317C,V299L",Bld/Bone mar
258,258,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
259,259,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT amplification)|GRCh38,8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
260,260,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,3905.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
261,261,,dbSNP:rs35756741,rs35756741 mutation in cyclin dependent kinase inhibitor 1B (CDKN1B),presence of,risk_biomarker,blood (UN:0000178),75388-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111276/HP_0001787,UPKB:P46527 (CDKN1B oncogenic mutation)|GRCh38,,,ENSG00000111276,,cyclin dependent kinase inhibitor 1B,,Bld/Tiss
262,262,,dbSNP:rs2584124,rs2584124 mutation in neurotrophic receptor tyrosine kinase 3 (NTRK3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140538/HP_0001787,UPKB:Q16288 (NTRK3 fusion)|GRCh38,3458.0,,ENSG00000140538,,neurotrophic receptor tyrosine kinase 3,,
263,263,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,eosinophilic chronic leukemia,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
264,264,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (L798I) (inframe_insertion:729-761)|GRCh38 ,3910.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,L798I) (inframe_insertion:729-761,Bld/Tiss
265,265,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,4001.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
266,266,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (M1268T)|GRCh38 ,4451.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",M1268T,Bld/Tiss
267,267,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,cholangiocarcinoma (DOID:4947),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (N549H,V564F,K659M,L617V,K641R,R565A)|GRCh38 ",4947.0,,ENSG00000066468,,fibroblast growth factor receptor 2,"N549H,V564F,K659M,L617V,K641R,R565A",Bld/Tiss
268,268,,dbSNP:rs987106,rs987106 mutation in interleukin 7 receptor (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168685/HP_0001787,UPKB:P16871 (S185C)|GRCh38 ,9952.0,,ENSG00000168685,,interleukin 7 receptor,S185C,
269,269,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (D769Y,D769H,R896C,G309E,S310F,S310Y,C311R) (inframe_insertion:775-881)|GRCh38 ",3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"D769Y,D769H,R896C,G309E,S310F,S310Y,C311R) (inframe_insertion:775-881",Tiss
270,270,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,"UPKB:P31749 (Q79K,E17K)|GRCh38 ",8923.0,,ENSG00000142208,,AKT serine/threonine kinase 1,"Q79K,E17K",Bld/Tiss
271,271,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
272,272,,dbSNP:rs17758695,rs17758695 mutation in BCL2 apoptosis regulator (BCL2),presence of,risk_biomarker,blood (UN:0000178),21095-5,multiple myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171791/HP_0001787,UPKB:P10415 (BCL2 overexpression)|GRCh38,9538.0,,ENSG00000171791,,BCL2 apoptosis regulator,,Bld/Tiss
273,273,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,UPKB:P04629 (NTRK1 fusion)|GRCh38,3910.0,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,,Tiss
274,274,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761)|GRCh38 ",3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761",Bld/Tiss
275,275,,dbSNP:rs7163762,rs7163762 mutation in isocitrate dehydrogenase (NADP(+)) 2 (IDH2),presence of,risk_biomarker,blood (UN:0000178),100023-1,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000182054/HP_0001787,UPKB:P48735 (R172)|GRCh38 ,4607.0,,ENSG00000182054,,isocitrate dehydrogenase (NADP(+)) 2,R172,Bld/Tiss
276,276,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
277,277,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
278,278,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET kinase domain mutation)|GRCh38,4451.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
279,279,,dbSNP:rs35347644,rs35347644 mutation in potassium inwardly rectifying channel subfamily J member 5 (KCNJ5),presence of,risk_biomarker,,,adrenal adenoma (DOID:656),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120457/HP_0001787,UPKB:P48544 (L168R)|GRCh38 ,656.0,,ENSG00000120457,,potassium inwardly rectifying channel subfamily J member 5,L168R,
280,280,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,"UPKB:Q96SW2 (Q100*,R283K)|GRCh38 ",9538.0,,ENSG00000113851,,cereblon,"Q100*,R283K",
281,281,,dbSNP:rs998584,rs998584 mutation in vascular endothelial growth factor A (VEGFA),presence of,risk_biomarker,blood (UN:0000178),94470-2,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000112715/HP_0001787,UPKB:P15692 (VEGFA amplification)|GRCh38,,,ENSG00000112715,,vascular endothelial growth factor A,,Bld/Tiss
282,282,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (G776L) (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,G776L) (inframe_insertion:775-881,Tiss
283,283,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
284,284,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
285,285,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (I1171T)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,I1171T,Bld/Tiss
286,286,,dbSNP:rs3176336,rs3176336 mutation in cyclin dependent kinase inhibitor 1A (CDKN1A),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000124762/HP_0001787,UPKB:P38936 (CDKN1A deletion)|GRCh38,,,ENSG00000124762,,cyclin dependent kinase inhibitor 1A,,
287,287,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
288,288,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (F2108L)|GRCh38 ,,,ENSG00000198793,,mechanistic target of rapamycin kinase,F2108L,
289,289,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (PTEN)",presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (PTEN oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
290,290,,dbSNP:rs71487219,"rs71487219 mutation in HRas proto-oncogene, GTPase (HRAS)",presence of,risk_biomarker,blood (UN:0000178),21698-6,cervical carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000174775/HP_0001787,UPKB:P01112 (HRAS oncogenic mutation)|GRCh38,,,ENSG00000174775,,"HRas proto-oncogene, GTPase",,Bld/Tiss
291,291,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,"UPKB:P01116 (12,13)|GRCh38 ",50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase","12,13",Bld/Tiss
292,292,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
293,293,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,9952.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
294,294,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,4001.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
295,295,,dbSNP:rs6916554,rs6916554 mutation in solute carrier family 29 member 1 (Augustine blood group) (SLC29A1),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000112759/HP_0001787,UPKB:Q99808 (SLC29A1 oncogenic mutation)|GRCh38,4007.0,,ENSG00000112759,,solute carrier family 29 member 1 (Augustine blood group),,
296,296,,dbSNP:rs35756741,rs35756741 mutation in cyclin dependent kinase inhibitor 1B (CDKN1B),presence of,risk_biomarker,blood (UN:0000178),75388-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111276/HP_0001787,UPKB:P46527 (CDKN1B deletion)|GRCh38,,,ENSG00000111276,,cyclin dependent kinase inhibitor 1B,,Bld/Tiss
297,297,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (G465R) (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,G465R) (inframe_insertion:729-761,Bld/Tiss
298,298,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,3905.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
299,299,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
300,300,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
301,301,,dbSNP:rs2890652,rs2890652 mutation in LDL receptor related protein 1B (LRP1B),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168702/HP_0001787,UPKB:Q9NZR2 (LRP1B oncogenic mutation)|GRCh38,4001.0,,ENSG00000168702,,LDL receptor related protein 1B,,
302,302,,dbSNP:rs744617,rs744617 mutation in PML nuclear body scaffold (PML-RARA),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140464/HP_0001787,UPKB:P29590 (PML-RARA fusion)|GRCh38,9119.0,,ENSG00000140464,,PML nuclear body scaffold,,
303,303,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 overexpression)|GRCh38,4451.0,,ENSG00000120217,,CD274 molecule,,
304,304,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
305,305,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
306,306,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
307,307,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A deletion)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
308,308,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,4001.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
309,309,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,4007.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
310,310,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
311,311,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
312,312,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 deletion)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
313,313,,dbSNP:rs12667978,"rs12667978 mutation in smoothened, frizzled class receptor (SMO)",presence of,risk_biomarker,,,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000128602/HP_0001787,UPKB:Q99835 (P641A)|GRCh38 ,3905.0,,ENSG00000128602,,"smoothened, frizzled class receptor",P641A,
314,314,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
315,315,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
316,316,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (A266),inframe insertion (S267)|GRCh38 ",3905.0,,ENSG00000066468,,fibroblast growth factor receptor 2,"A266),inframe insertion (S267",Bld/Tiss
317,317,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
318,318,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT wildtype)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
319,319,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (V600E)|GRCh38 ,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",V600E,Bld/Tiss
320,320,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
321,321,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
322,322,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (L485),inframe deletion (P490)|GRCh38 ",,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","L485),inframe deletion (P490",Bld/Tiss
323,323,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
324,324,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
325,325,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
326,326,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,leukemia (DOID:1240),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,1240.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
327,327,,dbSNP:rs357564,rs357564 mutation in patched 1 (PTCH1),presence of,risk_biomarker,,,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000185920/HP_0001787,UPKB:Q13635 (PTCH1 oncogenic mutation)|GRCh38,50902.0,,ENSG00000185920,,patched 1,,
328,328,,dbSNP:rs12093576,rs12093576 mutation in AKT serine/threonine kinase 3 (AKT3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117020/HP_0001787,UPKB:Q9Y243 (AKT3 fusion)|GRCh38,3458.0,,ENSG00000117020,,AKT serine/threonine kinase 3,,
329,329,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion)|GRCh38,,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
330,330,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (N1421D)|GRCh38 ,5517.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,N1421D,
331,331,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,UPKB:P21802 (FGFR2 amplification)|GRCh38,5517.0,,ENSG00000066468,,fibroblast growth factor receptor 2,,Bld/Tiss
332,332,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761",Bld/Tiss
333,333,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 oncogenic mutation)|GRCh38,4451.0,,ENSG00000163930,,BRCA1 associated protein 1,,
334,334,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,5517.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
335,335,,dbSNP:rs73047773,"rs73047773 mutation in ERCC excision repair 1, endonuclease non-catalytic subunit (ERCC1)",presence of,risk_biomarker,tissue (UN:0000479),69572-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012061/HP_0001787,UPKB:P07992 (ERCC1 oncogenic mutation)|GRCh38,3905.0,,ENSG00000012061,,"ERCC excision repair 1, endonuclease non-catalytic subunit",,Tiss
336,336,,dbSNP:rs347896,rs347896 mutation in NUT midline carcinoma family member 1 (BRD4-C15orf55),presence of,risk_biomarker,,,nut midline carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000184507/HP_0001787,UPKB:Q86Y26 (BRD4-C15orf55 fusion)|GRCh38,,,ENSG00000184507,,NUT midline carcinoma family member 1,,
337,337,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,50861.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
338,338,,dbSNP:rs12714871,"rs12714871 mutation in Raf-1 proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,osteosarcoma (DOID:3347),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000132155/HP_0001787,UPKB:P04049 (RAF1 overexpression)|GRCh38,3347.0,,ENSG00000132155,,"Raf-1 proto-oncogene, serine/threonine kinase",,Bld/Tiss
339,339,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,3458.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
340,340,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
341,341,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,4007.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
342,342,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (K57T)|GRCh38 ,50861.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,K57T,Bld/Tiss
343,343,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,G469A)|GRCh38 ",3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,G469A",Bld/Tiss
344,344,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (L869R) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,L869R) (inframe_insertion:775-881,Tiss
345,345,,dbSNP:rs2298650,rs2298650 mutation in Cbl proto-oncogene (CBL),presence of,risk_biomarker,,,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110395/HP_0001787,"UPKB:P22681 (Y371H,C384R)|GRCh38 ",,,ENSG00000110395,,Cbl proto-oncogene,"Y371H,C384R",
346,346,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3-ITD),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (FLT3-ITD)|GRCh38,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,,
347,347,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 9 or 17)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
348,348,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK amplification)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
349,349,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761)|GRCh38 ",3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861Q,L861R) (inframe_insertion:729-761",Bld/Tiss
350,350,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A deletion)|GRCh38,8923.0,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
351,351,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (K650)|GRCh38 ,9538.0,,ENSG00000068078,,fibroblast growth factor receptor 3,K650,Bld/Tiss
352,352,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (IDH1 oncogenic mutation)|GRCh38,9119.0,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,,Bld/Tiss
353,353,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
354,354,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (SH2B3),presence of,risk_biomarker,,,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,UPKB:Q9UQQ2 (SH2B3 deletion)|GRCh38,,,ENSG00000111252,,SH2B adaptor protein 3,,
355,355,,dbSNP:rs1004467,rs1004467 mutation in cytochrome P450 family 17 subfamily A member 1 (CYP17A1),presence of,risk_biomarker,blood (UN:0000178),77057-8,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148795/HP_0001787,UPKB:P05093 (CYP17A1 expression)|GRCh38,2526.0,,ENSG00000148795,,cytochrome P450 family 17 subfamily A member 1,,Bld/Tiss
356,356,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (D769Y,D769H,R896C,G309E,S310F,S310Y,C311R) (inframe_insertion:775-881)|GRCh38 ",,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"D769Y,D769H,R896C,G309E,S310F,S310Y,C311R) (inframe_insertion:775-881",Tiss
357,357,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
358,358,,dbSNP:rs200368423,rs200368423 mutation in notch receptor 2 (NOTCH2),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134250/HP_0001787,UPKB:Q04721 (missense in TAD or truncating in Cterm-PEST domain)|GRCh38 ,3458.0,,ENSG00000134250,,notch receptor 2,missense in TAD or truncating in Cterm-PEST domain,
359,359,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
360,360,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD splice donor variant)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
361,361,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (FGFR3 fusion)|GRCh38,4007.0,,ENSG00000068078,,fibroblast growth factor receptor 3,,Bld/Tiss
362,362,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
363,363,,dbSNP:rs4802073,rs4802073 mutation in AKT serine/threonine kinase 2 (AKT2),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105221/HP_0001787,UPKB:P31751 (AKT2 amplification)|GRCh38,,,ENSG00000105221,,AKT serine/threonine kinase 2,,
364,364,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
365,365,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (A775YVMA),inframe insertion (G776VC) (inframe_insertion:775-881)|GRCh38 ",3905.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"A775YVMA),inframe insertion (G776VC) (inframe_insertion:775-881",Tiss
366,366,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (P124)|GRCh38 ,8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,P124,Bld/Tiss
367,367,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,9952.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
368,368,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
369,369,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
370,370,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
371,371,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2),presence of,risk_biomarker,blood (UN:0000178),43399-5,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (JAK2 oncogenic mutation)|GRCh38,8923.0,,ENSG00000096968,,Janus kinase 2,,Bld/Tiss
372,372,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (PIK3CB oncogenic mutation)|GRCh38,5520.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",,
373,373,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (E203K,Q56P,K57E)|GRCh38 ",8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"E203K,Q56P,K57E",Bld/Tiss
374,374,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
375,375,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (V560)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",V560,Bld/Tiss
376,376,,dbSNP:rs56313227,rs56313227 mutation in histone deacetylase 2 (HDAC2),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196591/HP_0001787,UPKB:Q92769 (HDAC2 biallelic inactivation)|GRCh38,2526.0,,ENSG00000196591,,histone deacetylase 2,,
377,377,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,2871.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
378,378,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
379,379,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,"UPKB:Q12882 (I560S,D949V)|GRCh38 ",,,ENSG00000188641,,dihydropyrimidine dehydrogenase,"I560S,D949V",Bld/Tiss
380,380,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
381,381,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation)|GRCh38,3905.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
382,382,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
383,383,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
384,384,,dbSNP:rs7163762,rs7163762 mutation in isocitrate dehydrogenase (NADP(+)) 2 (IDH2),presence of,risk_biomarker,blood (UN:0000178),100023-1,cholangiocarcinoma (DOID:4947),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000182054/HP_0001787,UPKB:P48735 (IDH2 oncogenic mutation)|GRCh38,4947.0,,ENSG00000182054,,isocitrate dehydrogenase (NADP(+)) 2,,Bld/Tiss
385,385,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2),presence of,risk_biomarker,blood (UN:0000178),43399-5,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (V617F)|GRCh38 ,9119.0,,ENSG00000096968,,Janus kinase 2,V617F,Bld/Tiss
386,386,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
387,387,,dbSNP:rs62505473,rs62505473 mutation in fibroblast growth factor receptor 1 (FGFR1),presence of,risk_biomarker,blood (UN:0000178),42785-6,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000077782/HP_0001787,UPKB:P11362 (FGFR1 amplification)|GRCh38,,,ENSG00000077782,,fibroblast growth factor receptor 1,,Bld/Tiss
388,388,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,cervical squamous cell carcinoma (DOID:3744),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3744.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
389,389,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
390,390,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS amplification)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
391,391,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 deletion)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
392,392,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,4001.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
393,393,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
394,394,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,4001.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
395,395,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (C797S) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,C797S) (inframe_insertion:729-761,Bld/Tiss
396,396,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (P262H,G284R,Q809R)|GRCh38 ",,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"P262H,G284R,Q809R",
397,397,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
398,398,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761",Bld/Tiss
399,399,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,9538.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
400,400,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET-TPCN1),presence of,risk_biomarker,,,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET-TPCN1 fusion)|GRCh38,,,ENSG00000165731,,ret proto-oncogene,,
401,401,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
402,402,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (D769Y,D769H,R896C,V777L,V842I,G309A) (inframe_insertion:775-881)|GRCh38 ",3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"D769Y,D769H,R896C,V777L,V842I,G309A) (inframe_insertion:775-881",Tiss
403,403,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
404,404,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR amplification)|GRCh38,2526.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
405,405,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (1151T)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,1151T,Bld/Tiss
406,406,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
407,407,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,4001.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
408,408,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
409,409,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,60058.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
410,410,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600K)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600K",Bld/Tiss
411,411,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR overexpression)|GRCh38,3458.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
412,412,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,3908.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
413,413,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
414,414,,dbSNP:rs4148325,rs4148325 mutation in UDP glucuronosyltransferase family 1 member A1 (UGT1A1),presence of,risk_biomarker,blood (UN:0000178),34509-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000241635/HP_0001787,"UPKB:P22309 (G71R,P229Q)|GRCh38 ",,,ENSG00000241635,,UDP glucuronosyltransferase family 1 member A1,"G71R,P229Q",Bld/Tiss
415,415,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,neuroblastoma (DOID:769),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,769.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
416,416,,dbSNP:rs3743861,rs3743861 mutation in FA complementation group A (FANCA),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000187741/HP_0001787,UPKB:O15360 (FANCA oncogenic mutation)|GRCh38,2526.0,,ENSG00000187741,,FA complementation group A,,
417,417,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
418,418,,dbSNP:rs55664914,"rs55664914 mutation in SET domain containing 2, histone lysine methyltransferase (SETD2)",presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000181555/HP_0001787,UPKB:Q9BYW2 (SETD2 oncogenic mutation)|GRCh38,,,ENSG00000181555,,"SET domain containing 2, histone lysine methyltransferase",,
419,419,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,UPKB:Q96SW2 (CRBN undexpression)|GRCh38,9538.0,,ENSG00000113851,,cereblon,,
420,420,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
421,421,,dbSNP:rs2890652,rs2890652 mutation in LDL receptor related protein 1B (LRP1B),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168702/HP_0001787,UPKB:Q9NZR2 (LRP1B deletion)|GRCh38,4001.0,,ENSG00000168702,,LDL receptor related protein 1B,,
422,422,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
423,423,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD splice donor variant)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
424,424,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
425,425,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 amplification)|GRCh38,3382.0,,ENSG00000105810,,cyclin dependent kinase 6,,
426,426,,dbSNP:rs189087436,rs189087436 mutation in amphiregulin (AREG),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109321/HP_0001787,UPKB:P15514 (AREG amplification)|GRCh38,50861.0,,ENSG00000109321,,amphiregulin,,
427,427,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,retinoblastoma (DOID:768),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 oncogenic mutation)|GRCh38,768.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
428,428,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
429,429,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A deletion)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
430,430,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA wildtype)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
431,431,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,"UPKB:P01111 (12,13,59,61,117,146)|GRCh38 ",50861.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase","12,13,59,61,117,146",Bld/Tiss
432,432,,dbSNP:rs2184540,rs2184540 mutation in spleen associated tyrosine kinase (SYK),presence of,risk_biomarker,,,mantle cell lymphoma (DOID:0050746),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165025/HP_0001787,UPKB:P43405 (SYK amplification)|GRCh38,50746.0,,ENSG00000165025,,spleen associated tyrosine kinase,,
433,433,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,"UPKB:P08922 (S1986Y,S1986F)|GRCh38 ",3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase","S1986Y,S1986F",
434,434,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (T878A)|GRCh38 ,2526.0,,ENSG00000169083,,androgen receptor,T878A,Bld/Tiss
435,435,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (V299L)|GRCh38 ,,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",V299L,Bld/Bone mar
436,436,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,lymphangioleiomyomatosis (DOID:3319),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (TSC2 oncogenic mutation)|GRCh38,3319.0,,ENSG00000103197,,TSC complex subunit 2,,Bld/Tiss
437,437,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
438,438,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
439,439,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
440,440,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (Q56P,P124S,P124L)|GRCh38 ",8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"Q56P,P124S,P124L",Bld/Tiss
441,441,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,"UPKB:P22607 (K650,Y373C)|GRCh38 ",9538.0,,ENSG00000068078,,fibroblast growth factor receptor 3,"K650,Y373C",Bld/Tiss
442,442,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (V659E) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,V659E) (inframe_insertion:775-881,Tiss
443,443,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
444,444,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,60058.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
445,445,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 fusion)|GRCh38,9952.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
446,446,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 deletion)|GRCh38,4001.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
447,447,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
448,448,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
449,449,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (G2032R)|GRCh38 ,3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",G2032R,
450,450,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (30-336) (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,30-336) (inframe_insertion:729-761,Bld/Tiss
451,451,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PIK3CA),presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
452,452,,dbSNP:rs55664914,"rs55664914 mutation in SET domain containing 2, histone lysine methyltransferase (SETD2)",presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000181555/HP_0001787,UPKB:Q9BYW2 (SETD2 deletion)|GRCh38,,,ENSG00000181555,,"SET domain containing 2, histone lysine methyltransferase",,
453,453,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
454,454,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
455,455,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
456,456,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
457,457,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (V299L)|GRCh38 ,,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",V299L,Bld/Bone mar
458,458,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
459,459,,dbSNP:rs182197129,rs182197129 mutation in cyclin D1 (CCND1),presence of,risk_biomarker,blood (UN:0000178),21744-8,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110092/HP_0001787,UPKB:P24385 (CCND1 amplification)|GRCh38,50902.0,,ENSG00000110092,,cyclin D1,,Bld/Tiss
460,460,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (NF2),presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (NF2 deletion + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000146648,,epidermal growth factor receptor,,Amnio fld
461,461,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,50861.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
462,462,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,9119.0,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
463,463,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA amplification)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
464,464,,dbSNP:rs2299012,rs2299012 mutation in RAD50 double strand break repair protein (RAD50),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113522/HP_0001787,UPKB:Q92878 (L1237F)|GRCh38 ,,,ENSG00000113522,,RAD50 double strand break repair protein,L1237F,
465,465,,dbSNP:rs62505473,rs62505473 mutation in fibroblast growth factor receptor 1 (FGFR1),presence of,risk_biomarker,blood (UN:0000178),42785-6,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000077782/HP_0001787,UPKB:P11362 (FGFR1 amplification)|GRCh38,,,ENSG00000077782,,fibroblast growth factor receptor 1,,Bld/Tiss
466,466,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,4001.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
467,467,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4001.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
468,468,,dbSNP:rs4402166,rs4402166 mutation in AT-rich interaction domain 1A (ARID1A),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117713/HP_0001787,UPKB:O14497 (ARID1A oncogenic mutation)|GRCh38,,,ENSG00000117713,,AT-rich interaction domain 1A,,
469,469,,dbSNP:rs73047773,"rs73047773 mutation in ERCC excision repair 1, endonuclease non-catalytic subunit (ERCC1)",presence of,risk_biomarker,tissue (UN:0000479),69572-6,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012061/HP_0001787,UPKB:P07992 (ERCC1 overexpression)|GRCh38,4007.0,,ENSG00000012061,,"ERCC excision repair 1, endonuclease non-catalytic subunit",,Tiss
470,470,,dbSNP:rs189211472,rs189211472 mutation in RAD51 paralog C (RAD51C),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000108384/HP_0001787,UPKB:O43502 (RAD51C oncogenic mutation)|GRCh38,4001.0,,ENSG00000108384,,RAD51 paralog C,,
471,471,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
472,472,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
473,473,,dbSNP:rs1950526,rs1950526 mutation in forkhead box A1 (FOXA1),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000129514/HP_0001787,UPKB:P55317 (FOXA1 amplification)|GRCh38,50861.0,,ENSG00000129514,,forkhead box A1,,
474,474,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (F129L,L215P,I103N,P124)|GRCh38 ",,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"F129L,L215P,I103N,P124",Bld/Tiss
475,475,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816V)|GRCh38 ,9119.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816V,Bld/Tiss
476,476,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA-FIP1L1),presence of,risk_biomarker,,,hyper eosinophilic advanced snydrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA-FIP1L1 fusion)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,
477,477,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,3905.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
478,478,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,4007.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
479,479,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (56-60)|GRCh38 ,4001.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,56-60,Bld/Tiss
480,480,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
481,481,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,UPKB:Q9UQQ2 (S185C)|GRCh38 ,9952.0,,ENSG00000111252,,SH2B adaptor protein 3,S185C,
482,482,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
483,483,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (L718) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,L718) (inframe_insertion:729-761,Bld/Tiss
484,484,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
485,485,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,malignant astrocytoma (DOID:3069),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3069.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
486,486,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN biallelic inactivation)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
487,487,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,leukemia (DOID:1240),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,1240.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
488,488,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
489,489,,dbSNP:rs3176336,rs3176336 mutation in cyclin dependent kinase inhibitor 1A (CDKN1A),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000124762/HP_0001787,UPKB:P38936 (CDKN1A oncogenic mutation)|GRCh38,,,ENSG00000124762,,cyclin dependent kinase inhibitor 1A,,
490,490,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
491,491,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
492,492,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,5517.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
493,493,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
494,494,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,9538.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
495,495,,dbSNP:rs1447597871,rs1447597871 mutation in cadherin 1 (CDH1),presence of,risk_biomarker,blood (UN:0000178),21652-3,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000039068/HP_0001787,UPKB:P12830 (CDH1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000039068,,cadherin 1,,Bld/Tiss
496,496,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
497,497,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
498,498,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
499,499,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
500,500,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
501,501,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 oncogenic mutation)|GRCh38,,,ENSG00000135446,,cyclin dependent kinase 4,,
502,502,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (G12)|GRCh38 ,9952.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",G12,Bld/Tiss
503,503,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
504,504,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (A289V,R108K,G598V,T263P) (inframe_insertion:729-761)|GRCh38 ",,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"A289V,R108K,G598V,T263P) (inframe_insertion:729-761",Bld/Tiss
505,505,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (769-770) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,769-770) (inframe_insertion:729-761,Bld/Tiss
506,506,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (N822K)|GRCh38 ,9119.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",N822K,Bld/Tiss
507,507,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (F2108L)|GRCh38 ,,,ENSG00000198793,,mechanistic target of rapamycin kinase,F2108L,
508,508,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 11)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
509,509,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861Q,G719A,G719S,G719C,G719D,L747S,S768I,L861P,L861R) (inframe_insertion:729-761",Bld/Tiss
510,510,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4607.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
511,511,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
512,512,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
513,513,,dbSNP:rs2295795,rs2295795 mutation in carbonic anhydrase 9 (CA9),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000107159/HP_0001787,UPKB:Q16790 (CA9 overexpression)|GRCh38,4451.0,,ENSG00000107159,,carbonic anhydrase 9,,
514,514,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (SH2B3),presence of,risk_biomarker,,,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,UPKB:Q9UQQ2 (SH2B3 oncogenic mutation)|GRCh38,,,ENSG00000111252,,SH2B adaptor protein 3,,
515,515,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
516,516,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
517,517,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
518,518,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
519,519,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3908.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
520,520,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (H1112L)|GRCh38 ,,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",H1112L,Bld/Tiss
521,521,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,"UPKB:P36888 (D835,Y842)|GRCh38 ",9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,"D835,Y842",Bld/Tiss
522,522,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,9952.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
523,523,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3905.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
524,524,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,"UPKB:Q96SW2 (Q100*,R283K)|GRCh38 ",9538.0,,ENSG00000113851,,cereblon,"Q100*,R283K",
525,525,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
526,526,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
527,527,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 deletion)|GRCh38,2526.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
528,528,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (ROS1 fusion)|GRCh38,3908.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",,
529,529,,dbSNP:rs2584124,rs2584124 mutation in neurotrophic receptor tyrosine kinase 3 (NTRK3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140538/HP_0001787,UPKB:Q16288 (G623R)|GRCh38 ,,,ENSG00000140538,,neurotrophic receptor tyrosine kinase 3,G623R,
530,530,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK amplification)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
531,531,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
532,532,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600R)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600R,Bld/Tiss
533,533,,dbSNP:rs2636668,rs2636668 mutation in inositol polyphosphate-4-phosphatase type II B (INPP4B),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109452/HP_0001787,UPKB:O15327 (INPP4B deletion)|GRCh38,3458.0,,ENSG00000109452,,inositol polyphosphate-4-phosphatase type II B,,
534,534,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,neurofibroma (DOID:962),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,962.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
535,535,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
536,536,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
537,537,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2),presence of,risk_biomarker,blood (UN:0000178),43399-5,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (V617F)|GRCh38 ,9119.0,,ENSG00000096968,,Janus kinase 2,V617F,Bld/Tiss
538,538,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
539,539,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,"UPKB:P01116 (12,13,59,61,117,146)|GRCh38 ",50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase","12,13,59,61,117,146",Bld/Tiss
540,540,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 deletion)|GRCh38,4007.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
541,541,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
542,542,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,4905.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
543,543,,dbSNP:rs1050828,rs1050828 mutation in glucose-6-phosphate dehydrogenase (G6PD),presence of,risk_biomarker,blood (UN:0000178),21680-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000160211/HP_0001787,UPKB:P11413 (V98M) + G6PD (N156D)|GRCh38 ,,,ENSG00000160211,,glucose-6-phosphate dehydrogenase,V98M) + G6PD (N156D,Bld/Tiss
544,544,,dbSNP:rs2473181,rs2473181 mutation in stromal antigen 2 (STAG2),presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000101972/HP_0001787,UPKB:Q8N3U4 (STAG2 oncogenic mutation)|GRCh38,,,ENSG00000101972,,stromal antigen 2,,
545,545,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT splice acceptor variant)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
546,546,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
547,547,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (CDK4),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (CDK4 amplification + RB1 expression)|GRCh38,3382.0,,ENSG00000139687,,RB transcriptional corepressor 1,,
548,548,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (L1196M)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,L1196M,Bld/Tiss
549,549,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (P753S) (inframe_insertion:729-761)|GRCh38 ,11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,P753S) (inframe_insertion:729-761,Bld/Tiss
550,550,,dbSNP:rs1004467,rs1004467 mutation in cytochrome P450 family 17 subfamily A member 1 (CYP17A1),presence of,risk_biomarker,blood (UN:0000178),77057-8,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148795/HP_0001787,UPKB:P05093 (CYP17A1 expression)|GRCh38,2526.0,,ENSG00000148795,,cytochrome P450 family 17 subfamily A member 1,,Bld/Tiss
551,551,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
552,552,,dbSNP:rs6026578,rs6026578 mutation in GNAS complex locus (GNAS),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000087460/HP_0001787,UPKB:O95467 (R201)|GRCh38 ,,,ENSG00000087460,,GNAS complex locus,R201,
553,553,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,"UPKB:Q9UM73 (C1156Y,L1196M)|GRCh38 ",3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,"C1156Y,L1196M",Bld/Tiss
554,554,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR overexpression)|GRCh38,3458.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
555,555,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (E1408V)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,E1408V,Bld/Tiss
556,556,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
557,557,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,4001.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
558,558,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
559,559,,dbSNP:rs73000929,rs73000929 mutation in zinc finger and BTB domain containing 16 (ZBTB16),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109906/HP_0001787,UPKB:Q05516 (ZBTB16 undexpression)|GRCh38,2526.0,,ENSG00000109906,,zinc finger and BTB domain containing 16,,
560,560,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
561,561,,dbSNP:rs3088050,rs3088050 mutation in fibroblast growth factor receptor 4 (FGFR4),presence of,risk_biomarker,,,rhabdomyosarcoma (DOID:3247),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000160867/HP_0001787,"UPKB:P22455 (N535,V550)|GRCh38 ",3247.0,,ENSG00000160867,,fibroblast growth factor receptor 4,"N535,V550",
562,562,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
563,563,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,sarcoma (DOID:1115),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 oncogenic mutation)|GRCh38,1115.0,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
564,564,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (MAP2K1)",presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (P124S,I111S)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","P124S,I111S",Bld/Tiss
565,565,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (D835)|GRCh38 ,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,D835,Bld/Tiss
566,566,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
567,567,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,"UPKB:Q9UQQ2 (237-255),inframe deletion (237-255)|GRCh38 ",9952.0,,ENSG00000111252,,SH2B adaptor protein 3,"237-255),inframe deletion (237-255",
568,568,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (PIK3CB oncogenic mutation)|GRCh38,5520.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",,
569,569,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,UPKB:P04629 (NTRK1 fusion)|GRCh38,3910.0,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,,Tiss
570,570,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600K)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600K",Bld/Tiss
571,571,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,2526.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
572,572,,dbSNP:rs1736215,rs1736215 mutation in folliculin (FLCN),presence of,risk_biomarker,blood (UN:0000178),57963-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000154803/HP_0001787,UPKB:Q8NFG4 (FLCN deletion)|GRCh38,,,ENSG00000154803,,folliculin,,Bld/Tiss
573,573,,dbSNP:rs76939542,rs76939542 mutation in aurora kinase A (AURKA),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000087586/HP_0001787,UPKB:O14965 (AURKA amplification)|GRCh38,,,ENSG00000087586,,aurora kinase A,,
574,574,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
575,575,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (F877L)|GRCh38 ,2526.0,,ENSG00000169083,,androgen receptor,F877L,Bld/Tiss
576,576,,dbSNP:rs493786,rs493786 mutation in fibroblast growth factor 4 (FGF4),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000075388/HP_0001787,UPKB:P08620 (FGF4 amplification)|GRCh38,3458.0,,ENSG00000075388,,fibroblast growth factor 4,,
577,577,,dbSNP:rs12096443,rs12096443 mutation in cyclin dependent kinase inhibitor 2C (CDKN2C),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000123080/HP_0001787,UPKB:P42773 (CDKN2C deletion)|GRCh38,,,ENSG00000123080,,cyclin dependent kinase inhibitor 2C,,
578,578,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
579,579,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,retinoblastoma (DOID:768),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 deletion)|GRCh38,768.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
580,580,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,giant cell astrocytoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (TSC2 oncogenic mutation)|GRCh38,,,ENSG00000103197,,TSC complex subunit 2,,Bld/Tiss
581,581,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (V600E)|GRCh38 ,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",V600E,Bld/Tiss
582,582,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 amplification)|GRCh38,3382.0,,ENSG00000135446,,cyclin dependent kinase 4,,
583,583,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lagerhans cell histiocytosis,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600D,V600K,V600M,V600G,V600R)|GRCh38 ",,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600D,V600K,V600M,V600G,V600R",Bld/Tiss
584,584,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 oncogenic mutation)|GRCh38,5517.0,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
585,585,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
586,586,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (L597R)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",L597R,Bld/Tiss
587,587,,dbSNP:rs16999497,"rs16999497 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (SMARCA1)",presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000102038/HP_0001787,UPKB:P28370 (SMARCA1 oncogenic mutation)|GRCh38,,,ENSG00000102038,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",,
588,588,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A oncogenic mutation)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
589,589,,dbSNP:rs9332739,rs9332739 mutation in solute carrier family 44 member 4 (SLC44A4),presence of,risk_biomarker,,,pancreas adenocarcinoma (DOID:4074),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000204385/HP_0001787,UPKB:Q53GD3 (SLC44A4 overexpression)|GRCh38,4074.0,,ENSG00000204385,,solute carrier family 44 member 4,,
590,590,,dbSNP:rs7715167,rs7715167 mutation in nucleophosmin 1 (NPM1),presence of,risk_biomarker,blood (UN:0000178),54448-6,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000181163/HP_0001787,UPKB:P06748 (NPM1 oncogenic mutation)|GRCh38,9119.0,,ENSG00000181163,,nucleophosmin 1,,Bld/Tiss
591,591,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (E17K)|GRCh38 ,5520.0,,ENSG00000142208,,AKT serine/threonine kinase 1,E17K,Bld/Tiss
592,592,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD biallelic inactivation)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
593,593,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
594,594,,dbSNP:rs73047773,"rs73047773 mutation in ERCC excision repair 1, endonuclease non-catalytic subunit (ERCC1)",presence of,risk_biomarker,tissue (UN:0000479),69572-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012061/HP_0001787,UPKB:P07992 (ERCC1 deletion)|GRCh38,3905.0,,ENSG00000012061,,"ERCC excision repair 1, endonuclease non-catalytic subunit",,Tiss
595,595,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
596,596,,dbSNP:rs9825207,rs9825207 mutation in ATR serine/threonine kinase (ATR),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175054/HP_0001787,UPKB:Q13535 (ATR oncogenic mutation)|GRCh38,,,ENSG00000175054,,ATR serine/threonine kinase,,
597,597,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,UPKB:P21802 (FGFR2 fusion)|GRCh38,4607.0,,ENSG00000066468,,fibroblast growth factor receptor 2,,Bld/Tiss
598,598,,dbSNP:rs62348889,rs62348889 mutation in FAT atypical cadherin 1 (FAT1),presence of,risk_biomarker,,,head and neck squamous cell carcinoma (DOID:5520),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083857/HP_0001787,UPKB:Q14517 (FAT1 oncogenic mutation)|GRCh38,5520.0,,ENSG00000083857,,FAT atypical cadherin 1,,
599,599,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 overexpression)|GRCh38,2526.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
600,600,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
601,601,,dbSNP:rs9825207,rs9825207 mutation in ATR serine/threonine kinase (ATR),presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175054/HP_0001787,UPKB:Q13535 (ATR oncogenic mutation)|GRCh38,,,ENSG00000175054,,ATR serine/threonine kinase,,
602,602,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (S492R) (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,S492R) (inframe_insertion:729-761,Bld/Tiss
603,603,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 11)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
604,604,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
605,605,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 amplification)|GRCh38,3905.0,,ENSG00000135446,,cyclin dependent kinase 4,,
606,606,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (G12)|GRCh38 ,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",G12,Bld/Tiss
607,607,,dbSNP:rs13232767,rs13232767 mutation in enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2),presence of,risk_biomarker,blood (UN:0000178),96964-2,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000106462/HP_0001787,"UPKB:Q15910 (Y641,A677)|GRCh38 ",60058.0,,ENSG00000106462,,enhancer of zeste 2 polycomb repressive complex 2 subunit,"Y641,A677",Bld/Tiss
608,608,,dbSNP:rs35221880,"rs35221880 mutation in DNA polymerase epsilon, catalytic subunit (POLE)",presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000177084/HP_0001787,UPKB:Q07864 (268-471)|GRCh38 ,,,ENSG00000177084,,"DNA polymerase epsilon, catalytic subunit",268-471,
609,609,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PIK3CA),presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
610,610,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
611,611,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (Q61)|GRCh38 ,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",Q61,Bld/Tiss
612,612,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,UPKB:P21802 (FGFR2 amplification)|GRCh38,3458.0,,ENSG00000066468,,fibroblast growth factor receptor 2,,Bld/Tiss
613,613,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (S464L,G465R,I491M) (inframe_insertion:729-761)|GRCh38 ",50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"S464L,G465R,I491M) (inframe_insertion:729-761",Bld/Tiss
614,614,,dbSNP:rs11602347,rs11602347 mutation in insulin like growth factor 2 (IGF2),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000167244/HP_0001787,UPKB:P01344 (IGF2 amplification)|GRCh38,50861.0,,ENSG00000167244,,insulin like growth factor 2,,
615,615,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,"UPKB:P01111 (12,13,59,61,117,146)|GRCh38 ",50861.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase","12,13,59,61,117,146",Bld/Tiss
616,616,,dbSNP:rs350912,rs350912 mutation in mitogen-activated protein kinase kinase 2 (MAP2K2),presence of,risk_biomarker,blood (UN:0000178),60496-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000126934/HP_0001787,UPKB:P36507 (Q60P)|GRCh38 ,8923.0,,ENSG00000126934,,mitogen-activated protein kinase kinase 2,Q60P,Bld/Tiss
617,617,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2-BRAF),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (JAK2-BRAF fusion)|GRCh38,9952.0,,ENSG00000096968,,Janus kinase 2,,
618,618,,dbSNP:rs1050828,rs1050828 mutation in glucose-6-phosphate dehydrogenase (G6PD),presence of,risk_biomarker,blood (UN:0000178),21680-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000160211/HP_0001787,UPKB:P11413 (S218F)|GRCh38 ,,,ENSG00000160211,,glucose-6-phosphate dehydrogenase,S218F,Bld/Tiss
619,619,,dbSNP:rs72922276,rs72922276 mutation in Janus kinase 1 (JAK1),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162434/HP_0001787,UPKB:P23458 (S646F;R683)|GRCh38 ,9952.0,,ENSG00000162434,,Janus kinase 1,S646F;R683,
620,620,,dbSNP:rs107155,rs107155 mutation in G protein subunit alpha 11 (GNA11),presence of,risk_biomarker,blood (UN:0000178),100020-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000088256/HP_0001787,"UPKB:P29992 (Q209L,Q209P)|GRCh38 ",8923.0,,ENSG00000088256,,G protein subunit alpha 11,"Q209L,Q209P",Bld/Tiss
621,621,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
622,622,,dbSNP:rs3846706,rs3846706 mutation in colony stimulating factor 1 receptor (CSF1R),presence of,risk_biomarker,,,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000182578/HP_0001787,UPKB:P07333 (Y571D)|GRCh38 ,,,ENSG00000182578,,colony stimulating factor 1 receptor,Y571D,
623,623,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA-FIP1L1),presence of,risk_biomarker,,,eosinophilic chronic leukemia,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA-FIP1L1 fusion)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,
624,624,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (PTEN)",presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (PTEN deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
625,625,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,female germ cell tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
626,626,,dbSNP:rs201233223,rs201233223 mutation in SUZ12 polycomb repressive complex 2 subunit (SUZ12),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178691/HP_0001787,UPKB:Q15022 (SUZ12 oncogenic mutation)|GRCh38,,,ENSG00000178691,,SUZ12 polycomb repressive complex 2 subunit,,
627,627,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
628,628,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (ESR1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000091831,,estrogen receptor 1,,
629,629,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,3908.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
630,630,,dbSNP:rs4976033,rs4976033 mutation in phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1),presence of,risk_biomarker,,,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000145675/HP_0001787,UPKB:P27986 (PIK3R1 oncogenic mutation)|GRCh38,2871.0,,ENSG00000145675,,phosphoinositide-3-kinase regulatory subunit 1,,
631,631,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
632,632,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA wildtype)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
633,633,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (Y472C)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",Y472C,Bld/Tiss
634,634,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (RAC1)",presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (P29S)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",P29S,
635,635,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (L858R) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,L858R) (inframe_insertion:729-761,Bld/Tiss
636,636,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
637,637,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (TSC2 oncogenic mutation)|GRCh38,4007.0,,ENSG00000103197,,TSC complex subunit 2,,Bld/Tiss
638,638,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
639,639,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
640,640,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
641,641,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D820Y)|GRCh38 ,8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D820Y,Bld/Tiss
642,642,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3905.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
643,643,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
644,644,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
645,645,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM deletion)|GRCh38,4007.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
646,646,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,9119.0,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
647,647,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
648,648,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT biallelic inactivation)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
649,649,,dbSNP:rs3731246,rs3731246 mutation in cyclin dependent kinase inhibitor 2B (CDKN2B),presence of,risk_biomarker,blood (UN:0000178),21615-0,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147883/HP_0001787,UPKB:P42772 (CDKN2B oncogenic mutation)|GRCh38,,,ENSG00000147883,,cyclin dependent kinase inhibitor 2B,,Bld/Tiss
650,650,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
651,651,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600K)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600K",Bld/Tiss
652,652,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
653,653,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
654,654,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,4607.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
655,655,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
656,656,,dbSNP:rs200368423,rs200368423 mutation in notch receptor 2 (NOTCH2),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134250/HP_0001787,UPKB:Q04721 (missense in TAD or truncating in Cterm-PEST domain)|GRCh38 ,9952.0,,ENSG00000134250,,notch receptor 2,missense in TAD or truncating in Cterm-PEST domain,
657,657,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (PTEN)",presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (PTEN deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
658,658,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A oncogenic mutation)|GRCh38,8923.0,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
659,659,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
660,660,,dbSNP:rs493786,rs493786 mutation in fibroblast growth factor 4 (FGF4),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000075388/HP_0001787,UPKB:P08620 (FGF4 amplification)|GRCh38,3458.0,,ENSG00000075388,,fibroblast growth factor 4,,
661,661,,dbSNP:rs12096443,rs12096443 mutation in cyclin dependent kinase inhibitor 2C (CDKN2C),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000123080/HP_0001787,UPKB:P42773 (CDKN2C oncogenic mutation)|GRCh38,,,ENSG00000123080,,cyclin dependent kinase inhibitor 2C,,
662,662,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT biallelic inactivation)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
663,663,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600,Bld/Tiss
664,664,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 deletion + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
665,665,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PIK3CA),presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
666,666,,dbSNP:rs184227198,"rs184227198 mutation in ERCC excision repair 2, TFIIH core complex helicase subunit (ERCC2)",presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000104884/HP_0001787,UPKB:P18074 (ERCC2 oncogenic mutation)|GRCh38,4007.0,,ENSG00000104884,,"ERCC excision repair 2, TFIIH core complex helicase subunit",,
667,667,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 oncogenic mutation)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
668,668,,dbSNP:rs4148325,rs4148325 mutation in UDP glucuronosyltransferase family 1 member A1 (UGT1A1),presence of,risk_biomarker,blood (UN:0000178),34509-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000241635/HP_0001787,UPKB:P22309 (UGT1A1 biallelic inactivation)|GRCh38,,,ENSG00000241635,,UDP glucuronosyltransferase family 1 member A1,,Bld/Tiss
669,669,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 amplification)|GRCh38,60058.0,,ENSG00000105810,,cyclin dependent kinase 6,,
670,670,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,2871.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
671,671,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
672,672,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 deletion)|GRCh38,4451.0,,ENSG00000163930,,BRCA1 associated protein 1,,
673,673,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
674,674,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,"UPKB:P10275 (L702H,T878A)|GRCh38 ",2526.0,,ENSG00000169083,,androgen receptor,"L702H,T878A",Bld/Tiss
675,675,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
676,676,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
677,677,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (A829P,V654A,T670I)|GRCh38 ",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","A829P,V654A,T670I",Bld/Tiss
678,678,,dbSNP:rs35221880,"rs35221880 mutation in DNA polymerase epsilon, catalytic subunit (POLE)",presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000177084/HP_0001787,UPKB:Q07864 (POLE oncogenic mutation)|GRCh38,50861.0,,ENSG00000177084,,"DNA polymerase epsilon, catalytic subunit",,
679,679,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
680,680,,dbSNP:rs67009183,rs67009183 mutation in cyclin D2 (CCND2),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118971/HP_0001787,UPKB:P30279 (CCND2 amplification)|GRCh38,,,ENSG00000118971,,cyclin D2,,
681,681,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,"UPKB:P04629 (G595R,G667C)|GRCh38 ",50861.0,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,"G595R,G667C",Tiss
682,682,,dbSNP:rs56335522,rs56335522 mutation in erb-b2 receptor tyrosine kinase 4 (ERBB4),presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178568/HP_0001787,UPKB:Q15303 (ERBB4 fusion)|GRCh38,3910.0,,ENSG00000178568,,erb-b2 receptor tyrosine kinase 4,,
683,683,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
684,684,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
685,685,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
686,686,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
687,687,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
688,688,,dbSNP:rs357564,rs357564 mutation in patched 1 (PTCH1),presence of,risk_biomarker,,,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000185920/HP_0001787,UPKB:Q13635 (PTCH1 oncogenic mutation)|GRCh38,50902.0,,ENSG00000185920,,patched 1,,
689,689,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 overexpression)|GRCh38,4451.0,,ENSG00000120217,,CD274 molecule,,
690,690,,dbSNP:rs3743861,rs3743861 mutation in FA complementation group A (FANCA),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000187741/HP_0001787,UPKB:O15360 (FANCA deletion)|GRCh38,2526.0,,ENSG00000187741,,FA complementation group A,,
691,691,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD splice donor variant)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
692,692,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,3910.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
693,693,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (E255K,E255V,Y253H,F359V,F359C,F359I)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","E255K,E255V,Y253H,F359V,F359C,F359I",Bld/Bone mar
694,694,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
695,695,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
696,696,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (T798I) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,T798I) (inframe_insertion:775-881,Tiss
697,697,,dbSNP:P10398,"P10398 mutation in A-Raf proto-oncogene, serine/threonine kinase (ARAF)",presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000078061/HP_0001787,UPKB:P10398 (ARAF oncogenic mutation)|GRCh38,50861.0,,ENSG00000078061,,"A-Raf proto-oncogene, serine/threonine kinase",,
698,698,,dbSNP:rs7709909,rs7709909 mutation in mutS homolog 3 (MSH3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113318/HP_0001787,UPKB:P20585 (MSH3 oncogenic mutation)|GRCh38,,,ENSG00000113318,,mutS homolog 3,,
699,699,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
700,700,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
701,701,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,4001.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
702,702,,dbSNP:rs12448561,rs12448561 mutation in phospholipase C gamma 2 (PLCG2),presence of,risk_biomarker,blood (UN:0000178),99128-1,chronic lymphocytic leukemia (DOID:1040),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000197943/HP_0001787,"UPKB:P16885 (R665W,L845F)|GRCh38 ",1040.0,,ENSG00000197943,,phospholipase C gamma 2,"R665W,L845F",Bld/Tiss
703,703,,dbSNP:rs4253230,"rs4253230 mutation in ERCC excision repair 6, chromatin remodeling factor (ERCC6)",presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000225830/HP_0001787,UPKB:P0DP91 (ERCC6 oncogenic mutation)|GRCh38,4001.0,,ENSG00000225830,,"ERCC excision repair 6, chromatin remodeling factor",,
704,704,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,neuroblastoma (DOID:769),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,769.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
705,705,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
706,706,,dbSNP:rs187971642,rs187971642 mutation in serpin family B member 3 (SERPINB3),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000057149/HP_0001787,UPKB:P29508 (SERPINB3 oncogenic mutation)|GRCh38,8923.0,,ENSG00000057149,,serpin family B member 3,,
707,707,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,"UPKB:P16234 (V658A,P577S,R841K,H845Y,G853D)|GRCh38 ",8923.0,,ENSG00000134853,,platelet derived growth factor receptor alpha,"V658A,P577S,R841K,H845Y,G853D",Bld/Tiss
708,708,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 oncogenic mutation)|GRCh38,3382.0,,ENSG00000105810,,cyclin dependent kinase 6,,
709,709,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
710,710,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT wildtype)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
711,711,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (NF1)",presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (NF1 oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
712,712,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR overexpression)|GRCh38,2526.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
713,713,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR-RAD51),presence of,risk_biomarker,,,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (EGFR-RAD51 fusion)|GRCh38,3905.0,,ENSG00000146648,,epidermal growth factor receptor,,
714,714,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
715,715,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (HGF),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (HGF amplification + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,
716,716,,dbSNP:rs8187929,rs8187929 mutation in annexin A1 (ARID1A),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135046/HP_0001787,UPKB:P04083 (ARID1A oncogenic mutation + ANXA1 overexpression)|GRCh38,3458.0,,ENSG00000135046,,annexin A1,,
717,717,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (S257P,G361A,P261P)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","S257P,G361A,P261P",Bld/Tiss
718,718,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,50861.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
719,719,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (NF1)",presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (NF1 deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
720,720,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,myelodisplasic syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA fusion)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
721,721,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (V555M)|GRCh38 ,9538.0,,ENSG00000068078,,fibroblast growth factor receptor 3,V555M,Bld/Tiss
722,722,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,UPKB:P04629 (NTRK1 fusion)|GRCh38,50861.0,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,,Tiss
723,723,,dbSNP:rs13277355,"rs13277355 mutation in MYC proto-oncogene, bHLH transcription factor (MYC)",presence of,risk_biomarker,blood (UN:0000178),21750-5,neuroblastoma (DOID:769),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136997/HP_0001787,UPKB:P01106 (MYC amplification)|GRCh38,769.0,,ENSG00000136997,,"MYC proto-oncogene, bHLH transcription factor",,Bld/Tiss
724,724,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,4905.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
725,725,,dbSNP:rs6656611,rs6656611 mutation in EPH receptor A2 (EPHA2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142627/HP_0001787,UPKB:P29317 (G391R)|GRCh38 ,,,ENSG00000142627,,EPH receptor A2,G391R,
726,726,,dbSNP:rs182197129,rs182197129 mutation in cyclin D1 (CCND1),presence of,risk_biomarker,blood (UN:0000178),21744-8,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110092/HP_0001787,UPKB:P24385 (CCND1 amplification)|GRCh38,,,ENSG00000110092,,cyclin D1,,Bld/Tiss
727,727,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (H697Y)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",H697Y,Bld/Tiss
728,728,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
729,729,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
730,730,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,erdheim-chester histiocytosis,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600D,V600K,V600M,V600G,V600R)|GRCh38 ",,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600D,V600K,V600M,V600G,V600R",Bld/Tiss
731,731,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,hairy-cell leukemia,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
732,732,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
733,733,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (PRKCH)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (PRKCH amplification + ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
734,734,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 deletion)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
735,735,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
736,736,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
737,737,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (T315I)|GRCh38 ,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",T315I,Bld/Bone mar
738,738,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (Q2223K)|GRCh38 ,4451.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,Q2223K,
739,739,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,8552.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
740,740,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
741,741,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
742,742,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A oncogenic mutation)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
743,743,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2),presence of,risk_biomarker,blood (UN:0000178),43399-5,myelofibrosis (DOID:4971),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (V617F)|GRCh38 ,4971.0,,ENSG00000096968,,Janus kinase 2,V617F,Bld/Tiss
744,744,,dbSNP:rs116434758,rs116434758 mutation in G protein subunit alpha q (GNAQ),presence of,risk_biomarker,blood (UN:0000178),100021-5,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000156052/HP_0001787,UPKB:P50148 (Q209)|GRCh38 ,8923.0,,ENSG00000156052,,G protein subunit alpha q,Q209,Bld/Tiss
745,745,,dbSNP:rs56335522,rs56335522 mutation in erb-b2 receptor tyrosine kinase 4 (ERBB4),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178568/HP_0001787,"UPKB:Q15303 (E317K,E452K,R544W,R393W,E872K)|GRCh38 ",8923.0,,ENSG00000178568,,erb-b2 receptor tyrosine kinase 4,"E317K,E452K,R544W,R393W,E872K",
746,746,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (D594G,G469E)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","D594G,G469E",Bld/Tiss
747,747,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
748,748,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
749,749,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,"UPKB:P07949 (C634W,M918T)|GRCh38 ",,,ENSG00000165731,,ret proto-oncogene,"C634W,M918T",Bld/Tiss
750,750,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
751,751,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,UPKB:Q96SW2 (CRBN undexpression)|GRCh38,9538.0,,ENSG00000113851,,cereblon,,
752,752,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
753,753,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (R132)|GRCh38 ,,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,R132,Bld/Tiss
754,754,,dbSNP:rs7201449,"rs7201449 mutation in ERCC excision repair 4, endonuclease catalytic subunit (ERCC4)",presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175595/HP_0001787,UPKB:Q92889 (ERCC4 oncogenic mutation)|GRCh38,4001.0,,ENSG00000175595,,"ERCC excision repair 4, endonuclease catalytic subunit",,
755,755,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
756,756,,dbSNP:rs2073950,rs2073950 mutation in SH2B adaptor protein 3 (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000111252/HP_0001787,"UPKB:Q9UQQ2 (237-255),inframe deletion (237-255)|GRCh38 ",9952.0,,ENSG00000111252,,SH2B adaptor protein 3,"237-255),inframe deletion (237-255",
757,757,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
758,758,,dbSNP:rs56335522,rs56335522 mutation in erb-b2 receptor tyrosine kinase 4 (ERBB4),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000178568/HP_0001787,UPKB:Q15303 (H809G)|GRCh38 ,3458.0,,ENSG00000178568,,erb-b2 receptor tyrosine kinase 4,H809G,
759,759,,dbSNP:rs55799006,rs55799006 mutation in DNA methyltransferase 3 alpha (DNMT3A),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000119772/HP_0001787,UPKB:Q9Y6K1 (DNMT3A oncogenic mutation)|GRCh38,9119.0,,ENSG00000119772,,DNA methyltransferase 3 alpha,,
760,760,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,"UPKB:P51580 (A80P,Y240C,A154T,A167G)|GRCh38 ",,,ENSG00000137364,,thiopurine S-methyltransferase,"A80P,Y240C,A154T,A167G",Bld
761,761,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 9 or 11)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
762,762,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,basal cell carcinoma (DOID:2513),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 amplification)|GRCh38,2513.0,,ENSG00000120217,,CD274 molecule,,
763,763,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
764,764,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,neurofibroma (DOID:962),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,962.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
765,765,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
766,766,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,2526.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
767,767,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
768,768,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
769,769,,dbSNP:rs12167679,"rs12167679 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1)",presence of,risk_biomarker,,,malignant rhabdoid tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000099956/HP_0001787,UPKB:Q12824 (SMARCB1 oncogenic mutation)|GRCh38,,,ENSG00000099956,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",,
770,770,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
771,771,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
772,772,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
773,773,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
774,774,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (PRKCH)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (PRKCH amplification + ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
775,775,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
776,776,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS amplification)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
777,777,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
778,778,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
779,779,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,glioblastoma (DOID:3068),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3068.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
780,780,,dbSNP:rs4402166,rs4402166 mutation in AT-rich interaction domain 1A (ARID1A),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117713/HP_0001787,UPKB:O14497 (ARID1A oncogenic mutation)|GRCh38,4001.0,,ENSG00000117713,,AT-rich interaction domain 1A,,
781,781,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (FGFR3 fusion)|GRCh38,,,ENSG00000068078,,fibroblast growth factor receptor 3,,Bld/Tiss
782,782,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
783,783,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 17)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
784,784,,dbSNP:rs1333037,rs1333037 mutation in cyclin dependent kinase inhibitor 2A (CDKN2A),presence of,risk_biomarker,blood (UN:0000178),21614-3,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147889/HP_0001787,UPKB:P42771 (CDKN2A deletion)|GRCh38,,,ENSG00000147889,,cyclin dependent kinase inhibitor 2A,,Bld/Tiss
785,785,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET-TPCN1),presence of,risk_biomarker,,,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET-TPCN1 fusion)|GRCh38,,,ENSG00000165731,,ret proto-oncogene,,
786,786,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + EGFR oncogenic mutation)|GRCh38,3910.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
787,787,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,4905.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
788,788,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR-RAD51),presence of,risk_biomarker,,,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (EGFR-RAD51 fusion)|GRCh38,3908.0,,ENSG00000146648,,epidermal growth factor receptor,,
789,789,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,retinoblastoma (DOID:768),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 deletion)|GRCh38,768.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
790,790,,dbSNP:rs6656611,rs6656611 mutation in EPH receptor A2 (EPHA2),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142627/HP_0001787,UPKB:P29317 (EPHA2 amplification)|GRCh38,,,ENSG00000142627,,EPH receptor A2,,
791,791,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,9119.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
792,792,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,mesothelioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
793,793,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,4001.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
794,794,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
795,795,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3-ITD),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (FLT3-ITD)|GRCh38,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,,
796,796,,dbSNP:rs62236881,rs62236881 mutation in checkpoint kinase 2 (CHEK2),presence of,risk_biomarker,blood (UN:0000178),72518-4,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000183765/HP_0001787,UPKB:O96017 (CHEK2 deletion)|GRCh38,2526.0,,ENSG00000183765,,checkpoint kinase 2,,Bld/Tiss
797,797,,dbSNP:rs146566634,rs146566634 mutation in epiregulin (EREG),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000124882/HP_0001787,UPKB:O14944 (EREG amplification)|GRCh38,50861.0,,ENSG00000124882,,epiregulin,,
798,798,,dbSNP:rs1887428,rs1887428 mutation in Janus kinase 2 (JAK2),presence of,risk_biomarker,blood (UN:0000178),43399-5,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000096968/HP_0001787,UPKB:O60674 (JAK2 amplification)|GRCh38,3458.0,,ENSG00000096968,,Janus kinase 2,,Bld/Tiss
799,799,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
800,800,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,4007.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
801,801,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
802,802,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,50861.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
803,803,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (S252W,N550K)|GRCh38 ",2871.0,,ENSG00000066468,,fibroblast growth factor receptor 2,"S252W,N550K",Bld/Tiss
804,804,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
805,805,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
806,806,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
807,807,,dbSNP:rs2636668,rs2636668 mutation in inositol polyphosphate-4-phosphatase type II B (INPP4B),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109452/HP_0001787,UPKB:O15327 (INPP4B oncogenic mutation)|GRCh38,3458.0,,ENSG00000109452,,inositol polyphosphate-4-phosphatase type II B,,
808,808,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,"UPKB:Q02750 (P124S,I111S)|GRCh38 ",8923.0,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,"P124S,I111S",Bld/Tiss
809,809,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3905.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
810,810,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
811,811,,dbSNP:rs55646508,rs55646508 mutation in fibroblast growth factor 3 (FGF3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186895/HP_0001787,UPKB:P11487 (FGF3 amplification)|GRCh38,3458.0,,ENSG00000186895,,fibroblast growth factor 3,,
812,812,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
813,813,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
814,814,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
815,815,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET-TPCN1),presence of,risk_biomarker,,,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET-TPCN1 fusion)|GRCh38,,,ENSG00000165731,,ret proto-oncogene,,
816,816,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,2871.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
817,817,,dbSNP:rs116434758,rs116434758 mutation in G protein subunit alpha q (GNAQ),presence of,risk_biomarker,blood (UN:0000178),100021-5,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000156052/HP_0001787,UPKB:P50148 (Q209)|GRCh38 ,8923.0,,ENSG00000156052,,G protein subunit alpha q,Q209,Bld/Tiss
818,818,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
819,819,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET fusion)|GRCh38,3910.0,,ENSG00000165731,,ret proto-oncogene,,Bld/Tiss
820,820,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (T798I) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,T798I) (inframe_insertion:775-881,Tiss
821,821,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 oncogenic mutation)|GRCh38,,,ENSG00000105810,,cyclin dependent kinase 6,,
822,822,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,3905.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
823,823,,dbSNP:rs3002416,rs3002416 mutation in BCL6 corepressor (BCOR),presence of,risk_biomarker,,,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000183337/HP_0001787,UPKB:Q6W2J9 (BCOR oncogenic mutation)|GRCh38,5517.0,,ENSG00000183337,,BCL6 corepressor,,
824,824,,dbSNP:rs35589149,rs35589149 mutation in Rac family small GTPase 1 (RAC1),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000136238/HP_0001787,UPKB:P63000 (P29S)|GRCh38 ,8923.0,,ENSG00000136238,,Rac family small GTPase 1,P29S,
825,825,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
826,826,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
827,827,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 overexpression)|GRCh38,8923.0,,ENSG00000120217,,CD274 molecule,,
828,828,,dbSNP:rs1410492,rs1410492 mutation in cyclin D3 (CCND3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000112576/HP_0001787,UPKB:P30281 (CCND3 amplification)|GRCh38,,,ENSG00000112576,,cyclin D3,,
829,829,,dbSNP:rs12167679,"rs12167679 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1)",presence of,risk_biomarker,,,malignant rhabdoid tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000099956/HP_0001787,UPKB:Q12824 (SMARCB1 deletion)|GRCh38,,,ENSG00000099956,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",,
830,830,,dbSNP:rs55646508,rs55646508 mutation in fibroblast growth factor 3 (FGF3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186895/HP_0001787,UPKB:P11487 (FGF3 amplification)|GRCh38,3458.0,,ENSG00000186895,,fibroblast growth factor 3,,
831,831,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (P262H,G284R)|GRCh38 ",,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"P262H,G284R",
832,832,,dbSNP:rs265548,rs265548 mutation in Janus kinase 3 (JAK3),presence of,risk_biomarker,blood (UN:0000178),47963-4,megakaryoblastic leukemia,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105639/HP_0001787,"UPKB:P52333 (R657Q,I87T,Q501H)|GRCh38 ",,,ENSG00000105639,,Janus kinase 3,"R657Q,I87T,Q501H",Bld/Tiss
833,833,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
834,834,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (D1067Y)|GRCh38 ,3458.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",D1067Y,
835,835,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
836,836,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR overexpression)|GRCh38,3458.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
837,837,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,malignant astrocytoma (DOID:3069),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3069.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
838,838,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,2871.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
839,839,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,4007.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
840,840,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
841,841,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
842,842,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
843,843,,dbSNP:rs34620233,rs34620233 mutation in hypoxia inducible factor 1 subunit alpha (HIF1A),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000100644/HP_0001787,UPKB:Q16665 (HIF1A overexpression)|GRCh38,4451.0,,ENSG00000100644,,hypoxia inducible factor 1 subunit alpha,,
844,844,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,3905.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
845,845,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
846,846,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,50861.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
847,847,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
848,848,,dbSNP:rs4402166,rs4402166 mutation in AT-rich interaction domain 1A (ARID1A),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117713/HP_0001787,UPKB:O14497 (ARID1A amplification + ANXA1 overexpression)|GRCh38,3458.0,,ENSG00000117713,,AT-rich interaction domain 1A,,
849,849,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
850,850,,dbSNP:rs112672990,rs112672990 mutation in p21 (RAC1) activated kinase 1 (PAK1),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149269/HP_0001787,UPKB:Q13153 (PAK1 amplification)|GRCh38,8923.0,,ENSG00000149269,,p21 (RAC1) activated kinase 1,,
851,851,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
852,852,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (MET),presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000141736,,erb-b2 receptor tyrosine kinase 2,,Bld/Tiss
853,853,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 oncogenic mutation)|GRCh38,3382.0,,ENSG00000135446,,cyclin dependent kinase 4,,
854,854,,dbSNP:rs2299012,rs2299012 mutation in RAD50 double strand break repair protein (RAD50),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113522/HP_0001787,UPKB:Q92878 (L1237F)|GRCh38 ,,,ENSG00000113522,,RAD50 double strand break repair protein,L1237F,
855,855,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
856,856,,dbSNP:rs350912,rs350912 mutation in mitogen-activated protein kinase kinase 2 (MAP2K2),presence of,risk_biomarker,blood (UN:0000178),60496-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000126934/HP_0001787,"UPKB:P36507 (V35M,L46F,N126D,C125S)|GRCh38 ",8923.0,,ENSG00000126934,,mitogen-activated protein kinase kinase 2,"V35M,L46F,N126D,C125S",Bld/Tiss
857,857,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,9119.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
858,858,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN biallelic inactivation)|GRCh38,50861.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
859,859,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (K757R,E746G) (inframe_insertion:729-761)|GRCh38 ",3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"K757R,E746G) (inframe_insertion:729-761",Bld/Tiss
860,860,,dbSNP:rs191425998,rs191425998 mutation in F-box and WD repeat domain containing 7 (FBXW7),presence of,risk_biomarker,blood (UN:0000178),100028-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109670/HP_0001787,UPKB:Q969H0 (FBXW7 deletion)|GRCh38,,,ENSG00000109670,,F-box and WD repeat domain containing 7,,Bld/Tiss
861,861,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,"UPKB:P16234 (552-596,631-668,814-854)|GRCh38 ",,,ENSG00000134853,,platelet derived growth factor receptor alpha,"552-596,631-668,814-854",Bld/Tiss
862,862,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
863,863,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,neuroendocrine tumor (DOID:169),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,169.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
864,864,,dbSNP:rs182197129,rs182197129 mutation in cyclin D1 (CCND1),presence of,risk_biomarker,blood (UN:0000178),21744-8,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110092/HP_0001787,UPKB:P24385 (CCND1 amplification)|GRCh38,3905.0,,ENSG00000110092,,cyclin D1,,Bld/Tiss
865,865,,dbSNP:rs12714871,"rs12714871 mutation in Raf-1 proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000132155/HP_0001787,UPKB:P04049 (RAF1 fusion)|GRCh38,2526.0,,ENSG00000132155,,"Raf-1 proto-oncogene, serine/threonine kinase",,Bld/Tiss
866,866,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,"UPKB:P03372 (E380Q,537,538,L536,P535H)|GRCh38 ",3458.0,,ENSG00000091831,,estrogen receptor 1,"E380Q,537,538,L536,P535H",
867,867,,dbSNP:rs3731246,rs3731246 mutation in cyclin dependent kinase inhibitor 2B (CDKN2B),presence of,risk_biomarker,blood (UN:0000178),21615-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147883/HP_0001787,UPKB:P42772 (CDKN2B oncogenic mutation)|GRCh38,,,ENSG00000147883,,cyclin dependent kinase inhibitor 2B,,Bld/Tiss
868,868,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
869,869,,dbSNP:rs6541725,rs6541725 mutation in GLI family zinc finger 2 (GLI2),presence of,risk_biomarker,,,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000074047/HP_0001787,UPKB:P10070 (GLI2 amplification)|GRCh38,50902.0,,ENSG00000074047,,GLI family zinc finger 2,,
870,870,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (D816Y,D816F,D816V)|GRCh38 ",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","D816Y,D816F,D816V",Bld/Tiss
871,871,,dbSNP:rs71487219,"rs71487219 mutation in HRas proto-oncogene, GTPase (HRAS)",presence of,risk_biomarker,blood (UN:0000178),21698-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000174775/HP_0001787,UPKB:P01112 (HRAS oncogenic mutation)|GRCh38,,,ENSG00000174775,,"HRas proto-oncogene, GTPase",,Bld/Tiss
872,872,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 amplification)|GRCh38,,,ENSG00000105810,,cyclin dependent kinase 6,,
873,873,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
874,874,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,2871.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
875,875,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (P753S) (inframe_insertion:729-761)|GRCh38 ,11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,P753S) (inframe_insertion:729-761,Bld/Tiss
876,876,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 17)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
877,877,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 oncogenic mutation)|GRCh38,4451.0,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
878,878,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,3910.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
879,879,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (T315A,F317L,F317V,F317I,F317C,F317I,Y253H,E255K,E255V,F359V,F359C,F359I)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","T315A,F317L,F317V,F317I,F317C,F317I,Y253H,E255K,E255V,F359V,F359C,F359I",Bld/Bone mar
880,880,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,9538.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
881,881,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (D1067Y)|GRCh38 ,3458.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",D1067Y,
882,882,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,"UPKB:P16234 (552-596,631-668,814-854)|GRCh38 ",,,ENSG00000134853,,platelet derived growth factor receptor alpha,"552-596,631-668,814-854",Bld/Tiss
883,883,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (L755S,G309A,D769Y,D769H,R896C,V777L,V842I) (inframe_insertion:775-881)|GRCh38 ",3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"L755S,G309A,D769Y,D769H,R896C,V777L,V842I) (inframe_insertion:775-881",Tiss
884,884,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,biliary tract cancer (DOID:4607),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (L485W)|GRCh38 ,4607.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",L485W,Bld/Tiss
885,885,,dbSNP:rs12104396,rs12104396 mutation in phosphoinositide-3-kinase regulatory subunit 2 (PIK3R2),presence of,risk_biomarker,,,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105647/HP_0001787,"UPKB:O00459 (A171V,N561D)|GRCh38 ",2871.0,,ENSG00000105647,,phosphoinositide-3-kinase regulatory subunit 2,"A171V,N561D",
886,886,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (I1973F)|GRCh38 ,4451.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,I1973F,
887,887,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
888,888,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,11934.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
889,889,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
890,890,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (V600E)|GRCh38 ,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",V600E,Bld/Tiss
891,891,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,UPKB:P21860 (ERBB3 amplification)|GRCh38,50861.0,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,,
892,892,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (S492R,G465R,R451C,K467T) (inframe_insertion:729-761)|GRCh38 ",50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"S492R,G465R,R451C,K467T) (inframe_insertion:729-761",Bld/Tiss
893,893,,dbSNP:P10398,"P10398 mutation in A-Raf proto-oncogene, serine/threonine kinase (ARAF)",presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000078061/HP_0001787,UPKB:P10398 (ARAF oncogenic mutation)|GRCh38,50861.0,,ENSG00000078061,,"A-Raf proto-oncogene, serine/threonine kinase",,
894,894,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (FGFR3 oncogenic mutation)|GRCh38,4007.0,,ENSG00000068078,,fibroblast growth factor receptor 3,,Bld/Tiss
895,895,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,5517.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
896,896,,dbSNP:rs17758695,rs17758695 mutation in BCL2 apoptosis regulator (BCL2),presence of,risk_biomarker,blood (UN:0000178),21095-5,multiple myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171791/HP_0001787,UPKB:P10415 (BCL2 overexpression)|GRCh38,9538.0,,ENSG00000171791,,BCL2 apoptosis regulator,,Bld/Tiss
897,897,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT wildtype)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
898,898,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
899,899,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (Q61)|GRCh38 ,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",Q61,Bld/Tiss
900,900,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
901,901,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,mantle cell lymphoma (DOID:0050746),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 oncogenic mutation)|GRCh38,50746.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
902,902,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (F1174L)|GRCh38 ,,,ENSG00000171094,,ALK receptor tyrosine kinase,F1174L,Bld/Tiss
903,903,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
904,904,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 wildtype)|GRCh38,9119.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
905,905,,dbSNP:rs2800278,rs2800278 mutation in discoidin domain receptor tyrosine kinase 2 (DDR2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162733/HP_0001787,UPKB:Q16832 (S768R)|GRCh38 ,,,ENSG00000162733,,discoidin domain receptor tyrosine kinase 2,S768R,
906,906,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,4001.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
907,907,,dbSNP:rs6656611,rs6656611 mutation in EPH receptor A2 (EPHA2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142627/HP_0001787,UPKB:P29317 (G391R)|GRCh38 ,,,ENSG00000142627,,EPH receptor A2,G391R,
908,908,,dbSNP:rs1319859,rs1319859 mutation in insulin like growth factor 1 receptor (IGF1R),presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140443/HP_0001787,UPKB:P08069 (IGF1R amplification)|GRCh38,3910.0,,ENSG00000140443,,insulin like growth factor 1 receptor,,
909,909,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
910,910,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,hyper eosinophilic advanced snydrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (T674I)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,T674I,Bld/Tiss
911,911,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
912,912,,dbSNP:rs744617,rs744617 mutation in PML nuclear body scaffold (PML-RARA),presence of,risk_biomarker,,,acute promyelocytic leukemia (DOID:0060318),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140464/HP_0001787,UPKB:P29590 (PML-RARA fusion)|GRCh38,60318.0,,ENSG00000140464,,PML nuclear body scaffold,,
913,913,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1-YAP1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (ESR1-YAP1 fusion)|GRCh38,3458.0,,ENSG00000091831,,estrogen receptor 1,,
914,914,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,"UPKB:Q12882 (I560S,D949V)|GRCh38 ",,,ENSG00000188641,,dihydropyrimidine dehydrogenase,"I560S,D949V",Bld/Tiss
915,915,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3458.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
916,916,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
917,917,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (G284R,R103G)|GRCh38 ",4007.0,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"G284R,R103G",
918,918,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,"UPKB:Q9UM73 (F856S,A348D)|GRCh38 ",9119.0,,ENSG00000171094,,ALK receptor tyrosine kinase,"F856S,A348D",Bld/Tiss
919,919,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
920,920,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
921,921,,dbSNP:rs2768762,rs2768762 mutation in neurotrophic receptor tyrosine kinase 1 (NTRK1),presence of,risk_biomarker,tissue (UN:0000479),93813-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198400/HP_0001787,UPKB:P04629 (NTRK1 fusion)|GRCh38,,,ENSG00000198400,,neurotrophic receptor tyrosine kinase 1,,Tiss
922,922,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
923,923,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
924,924,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
925,925,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET-TPCN1),presence of,risk_biomarker,,,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET-TPCN1 fusion)|GRCh38,,,ENSG00000165731,,ret proto-oncogene,,
926,926,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (Y553N)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",Y553N,Bld/Tiss
927,927,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (NF2),presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (NF2 oncogenic mutation + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000146648,,epidermal growth factor receptor,,Amnio fld
928,928,,dbSNP:rs1805007,rs1805007 mutation in tubulin beta 3 class III (TUBB3),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000258947/HP_0001787,UPKB:Q13509 (TUBB3 overexpression)|GRCh38,4007.0,,ENSG00000258947,,tubulin beta 3 class III,,
929,929,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (L792) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,L792) (inframe_insertion:729-761,Bld/Tiss
930,930,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (G284R,V104M,R103G)|GRCh38 ",4007.0,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"G284R,V104M,R103G",
931,931,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
932,932,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,9952.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
933,933,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (K1771R)|GRCh38 ,5517.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,K1771R,
934,934,,dbSNP:rs193181528,rs193181528 mutation in CD274 molecule (CD274),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000120217/HP_0001787,UPKB:Q9NZQ7 (CD274 amplification)|GRCh38,,,ENSG00000120217,,CD274 molecule,,
935,935,,dbSNP:rs62505473,rs62505473 mutation in fibroblast growth factor receptor 1 (FGFR1),presence of,risk_biomarker,blood (UN:0000178),42785-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000077782/HP_0001787,UPKB:P11362 (FGFR1 amplification)|GRCh38,2871.0,,ENSG00000077782,,fibroblast growth factor receptor 1,,Bld/Tiss
936,936,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,neuroblastoma (DOID:769),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,769.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
937,937,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600K)|GRCh38 ",8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600K",Bld/Tiss
938,938,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,myelodisplasic syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
939,939,,dbSNP:rs6665912,"rs6665912 mutation in MCL1 apoptosis regulator, BCL2 family member (MCL1)",presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000143384/HP_0001787,UPKB:Q07820 (MCL1 amplification)|GRCh38,,,ENSG00000143384,,"MCL1 apoptosis regulator, BCL2 family member",,
940,940,,dbSNP:rs12714871,"rs12714871 mutation in Raf-1 proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000132155/HP_0001787,UPKB:P04049 (RAF1 fusion)|GRCh38,2526.0,,ENSG00000132155,,"Raf-1 proto-oncogene, serine/threonine kinase",,Bld/Tiss
941,941,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
942,942,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
943,943,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,50861.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
944,944,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (S310,L755,V777) (inframe_insertion:775-881)|GRCh38 ",,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"S310,L755,V777) (inframe_insertion:775-881",Tiss
945,945,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
946,946,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2526.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
947,947,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
948,948,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
949,949,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,"UPKB:P03372 (E380Q,537,538,L536,P535H)|GRCh38 ",3458.0,,ENSG00000091831,,estrogen receptor 1,"E380Q,537,538,L536,P535H",
950,950,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
951,951,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 oncogenic mutation)|GRCh38,8923.0,,ENSG00000163930,,BRCA1 associated protein 1,,
952,952,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM oncogenic mutation)|GRCh38,5517.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
953,953,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
954,954,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
955,955,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
956,956,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 oncogenic mutation)|GRCh38,2526.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
957,957,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3458.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
958,958,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
959,959,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
960,960,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,3910.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
961,961,,dbSNP:rs9825207,rs9825207 mutation in ATR serine/threonine kinase (ATR),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000175054/HP_0001787,UPKB:Q13535 (ATR deletion)|GRCh38,,,ENSG00000175054,,ATR serine/threonine kinase,,
962,962,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D820E)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D820E,Bld/Tiss
963,963,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 oncogenic mutation)|GRCh38,4007.0,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
964,964,,dbSNP:rs13062221,rs13062221 mutation in EPH receptor A3 (EPHA3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000044524/HP_0001787,UPKB:P29320 (EPHA3 amplification)|GRCh38,,,ENSG00000044524,,EPH receptor A3,,
965,965,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (Y1230C;Y1235D)|GRCh38 ,,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",Y1230C;Y1235D,Bld/Tiss
966,966,,dbSNP:rs68189791,rs68189791 mutation in neuregulin 1 (NRG1),presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157168/HP_0001787,UPKB:Q02297 (NRG1 fusion)|GRCh38,3910.0,,ENSG00000157168,,neuregulin 1,,
967,967,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 17)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
968,968,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (ESR1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000091831,,estrogen receptor 1,,
969,969,,dbSNP:rs12714871,"rs12714871 mutation in Raf-1 proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000132155/HP_0001787,UPKB:P04049 (RAF1 fusion)|GRCh38,2526.0,,ENSG00000132155,,"Raf-1 proto-oncogene, serine/threonine kinase",,Bld/Tiss
970,970,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
971,971,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3908.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
972,972,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR amplification)|GRCh38,2526.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
973,973,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK oncogenic mutation)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
974,974,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
975,975,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
976,976,,dbSNP:rs13337626,rs13337626 mutation in TSC complex subunit 2 (TSC2),presence of,risk_biomarker,blood (UN:0000178),48980-7,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000103197/HP_0001787,UPKB:P49815 (E66K)|GRCh38 ,2871.0,,ENSG00000103197,,TSC complex subunit 2,E66K,Bld/Tiss
977,977,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
978,978,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,4905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
979,979,,dbSNP:rs2646421,rs2646421 mutation in GATA binding protein 3 (GATA3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000107485/HP_0001787,UPKB:P23771 (GATA3 oncogenic mutation)|GRCh38,3458.0,,ENSG00000107485,,GATA binding protein 3,,
980,980,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,"UPKB:P51580 (A80P,Y240C,A154T,A167G)|GRCh38 ",,,ENSG00000137364,,thiopurine S-methyltransferase,"A80P,Y240C,A154T,A167G",Bld
981,981,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (755-759),inframe insertion (780GSP),inframe insertion (781GSP) (inframe_insertion:775-881)|GRCh38 ",3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"755-759),inframe insertion (780GSP),inframe insertion (781GSP) (inframe_insertion:775-881",Tiss
982,982,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
983,983,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,9119.0,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
984,984,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (V659E) (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,V659E) (inframe_insertion:775-881,Tiss
985,985,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
986,986,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,fibrous histiocytoma (DOID:4415),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (H238Y)|GRCh38 ,4415.0,,ENSG00000142208,,AKT serine/threonine kinase 1,H238Y,Bld/Tiss
987,987,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,9952.0,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
988,988,,dbSNP:rs62505473,rs62505473 mutation in fibroblast growth factor receptor 1 (FGFR1),presence of,risk_biomarker,blood (UN:0000178),42785-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000077782/HP_0001787,UPKB:P11362 (FGFR1 amplification)|GRCh38,3458.0,,ENSG00000077782,,fibroblast growth factor receptor 1,,Bld/Tiss
989,989,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
990,990,,dbSNP:rs12072739,rs12072739 mutation in dihydropyrimidine dehydrogenase (DPYD),presence of,risk_biomarker,blood (UN:0000178),45284-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000188641/HP_0001787,UPKB:Q12882 (DPYD biallelic inactivation)|GRCh38,,,ENSG00000188641,,dihydropyrimidine dehydrogenase,,Bld/Tiss
991,991,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,pediatric glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
992,992,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
993,993,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
994,994,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,11934.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
995,995,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3908.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
996,996,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 17)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
997,997,,dbSNP:rs12714871,"rs12714871 mutation in Raf-1 proto-oncogene, serine/threonine kinase (RAF1)",presence of,risk_biomarker,blood (UN:0000178),82537-2,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000132155/HP_0001787,"UPKB:P04049 (S257P,G361A,P261P)|GRCh38 ",8923.0,,ENSG00000132155,,"Raf-1 proto-oncogene, serine/threonine kinase","S257P,G361A,P261P",Bld/Tiss
998,998,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
999,999,,dbSNP:rs71487219,"rs71487219 mutation in HRas proto-oncogene, GTPase (HRAS)",presence of,risk_biomarker,blood (UN:0000178),21698-6,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000174775/HP_0001787,UPKB:P01112 (HRAS oncogenic mutation)|GRCh38,9119.0,,ENSG00000174775,,"HRas proto-oncogene, GTPase",,Bld/Tiss
1000,1000,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1001,1001,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (IDH1 oncogenic mutation)|GRCh38,9119.0,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,,Bld/Tiss
1002,1002,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1003,1003,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
1004,1004,,dbSNP:rs4976033,rs4976033 mutation in phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1),presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000145675/HP_0001787,UPKB:P27986 (PIK3R1 oncogenic mutation)|GRCh38,,,ENSG00000145675,,phosphoinositide-3-kinase regulatory subunit 1,,
1005,1005,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D820Y)|GRCh38 ,8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D820Y,Bld/Tiss
1006,1006,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (30-336) (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,30-336) (inframe_insertion:729-761,Bld/Tiss
1007,1007,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1008,1008,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,4905.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1009,1009,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
1010,1010,,dbSNP:rs140353819,rs140353819 mutation in zinc and ring finger 3 (ZNRF3),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000183579/HP_0001787,UPKB:Q9ULT6 (ZNRF3 oncogenic mutation)|GRCh38,50861.0,,ENSG00000183579,,zinc and ring finger 3,,
1011,1011,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,2526.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
1012,1012,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,UPKB:P22607 (Y373C)|GRCh38 ,9538.0,,ENSG00000068078,,fibroblast growth factor receptor 3,Y373C,Bld/Tiss
1013,1013,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1014,1014,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (H1112R)|GRCh38 ,4451.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",H1112R,Bld/Tiss
1015,1015,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
1016,1016,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1017,1017,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1018,1018,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (D1246V)|GRCh38 ,3910.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",D1246V,Bld/Tiss
1019,1019,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1020,1020,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 deletion)|GRCh38,,,ENSG00000163930,,BRCA1 associated protein 1,,
1021,1021,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1022,1022,,dbSNP:rs12167679,"rs12167679 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1)",presence of,risk_biomarker,,,malignant rhabdoid tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000099956/HP_0001787,UPKB:Q12824 (SMARCB1 oncogenic mutation)|GRCh38,,,ENSG00000099956,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",,
1023,1023,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1024,1024,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1025,1025,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (W290C,S320C,K660N)|GRCh38 ",,,ENSG00000066468,,fibroblast growth factor receptor 2,"W290C,S320C,K660N",Bld/Tiss
1026,1026,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (V600E,V600D,V600K,V600M,V600G,V600R)|GRCh38 ",3908.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","V600E,V600D,V600K,V600M,V600G,V600R",Bld/Tiss
1027,1027,,dbSNP:rs460976,rs460976 mutation in transmembrane serine protease 2 (TMPRSS2),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000184012/HP_0001787,UPKB:O15393 (TMPRSS2 fusion)|GRCh38,2526.0,,ENSG00000184012,,transmembrane serine protease 2,,
1028,1028,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,retinoblastoma (DOID:768),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 oncogenic mutation)|GRCh38,768.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
1029,1029,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1030,1030,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1031,1031,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
1032,1032,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1033,1033,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1034,1034,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (RAD50),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (L1237F)|GRCh38 ,,,ENSG00000149311,,ATM serine/threonine kinase,L1237F,
1035,1035,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1036,1036,,dbSNP:rs12167679,"rs12167679 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1)",presence of,risk_biomarker,,,malignant rhabdoid tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000099956/HP_0001787,UPKB:Q12824 (SMARCB1 deletion)|GRCh38,,,ENSG00000099956,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",,
1037,1037,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (KIT mutation in exon 9,11,13,14 or 17)|GRCh38",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1038,1038,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1039,1039,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (V843I) (inframe_insertion:729-761)|GRCh38 ,11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,V843I) (inframe_insertion:729-761,Bld/Tiss
1040,1040,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,3910.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1041,1041,,dbSNP:rs74911261,rs74911261 mutation in ATM serine/threonine kinase (ATM),presence of,risk_biomarker,blood (UN:0000178),21624-2,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000149311/HP_0001787,UPKB:Q13315 (ATM deletion)|GRCh38,50861.0,,ENSG00000149311,,ATM serine/threonine kinase,,Bld/Tiss
1042,1042,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
1043,1043,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,plexiform neurofibroma (DOID:5151),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,5151.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1044,1044,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,4001.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1045,1045,,dbSNP:rs78110118,rs78110118 mutation in MDM4 regulator of p53 (MDM4),presence of,risk_biomarker,,,sarcoma (DOID:1115),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198625/HP_0001787,UPKB:O15151 (MDM4 amplification)|GRCh38,1115.0,,ENSG00000198625,,MDM4 regulator of p53,,
1046,1046,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (L858R) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,L858R) (inframe_insertion:729-761,Bld/Tiss
1047,1047,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (D761Y) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,D761Y) (inframe_insertion:729-761,Bld/Tiss
1048,1048,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
1049,1049,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (G1123S)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,G1123S,Bld/Tiss
1050,1050,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (I788N)|GRCh38 ,3910.0,,ENSG00000165731,,ret proto-oncogene,I788N,Bld/Tiss
1051,1051,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1052,1052,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1053,1053,,dbSNP:rs987106,rs987106 mutation in interleukin 7 receptor (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168685/HP_0001787,"UPKB:P16871 (237-255),inframe deletion (237-255)|GRCh38 ",9952.0,,ENSG00000168685,,interleukin 7 receptor,"237-255),inframe deletion (237-255",
1054,1054,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,male germ cell tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
1055,1055,,dbSNP:rs2584124,rs2584124 mutation in neurotrophic receptor tyrosine kinase 3 (NTRK3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140538/HP_0001787,UPKB:Q16288 (NTRK3 fusion)|GRCh38,3458.0,,ENSG00000140538,,neurotrophic receptor tyrosine kinase 3,,
1056,1056,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1057,1057,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1058,1058,,dbSNP:rs145922731,rs145922731 mutation in FA complementation group C (FANCC),presence of,risk_biomarker,blood (UN:0000178),32639-7,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000158169/HP_0001787,UPKB:Q00597 (FANCC oncogenic mutation)|GRCh38,4007.0,,ENSG00000158169,,FA complementation group C,,Bld/Tiss
1059,1059,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
1060,1060,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioblastoma (DOID:3068),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (6-273) (inframe_insertion:729-761)|GRCh38 ,3068.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,6-273) (inframe_insertion:729-761,Bld/Tiss
1061,1061,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 deletion)|GRCh38,4451.0,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
1062,1062,,dbSNP:rs6511720,"rs6511720 mutation in SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4)",presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000127616/HP_0001787,UPKB:P51532 (SMARCA4 deletion)|GRCh38,4001.0,,ENSG00000127616,,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",,
1063,1063,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (M536I,M538I,I548V,N550,E566G,L618M,K660E)|GRCh38 ",2871.0,,ENSG00000066468,,fibroblast growth factor receptor 2,"M536I,M538I,I548V,N550,E566G,L618M,K660E",Bld/Tiss
1064,1064,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (AR overexpression)|GRCh38,3458.0,,ENSG00000169083,,androgen receptor,,Bld/Tiss
1065,1065,,dbSNP:rs36115365,rs36115365 mutation in telomerase reverse transcriptase (TERT),presence of,risk_biomarker,tissue (UN:0000479),95778-7,glioblastoma multiforme (DOID:3068),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000164362/HP_0001787,UPKB:O14746 (TERT promoters core)|GRCh38,3068.0,,ENSG00000164362,,telomerase reverse transcriptase,,Tiss
1066,1066,,dbSNP:rs12096443,rs12096443 mutation in cyclin dependent kinase inhibitor 2C (CDKN2C),presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000123080/HP_0001787,UPKB:P42773 (CDKN2C deletion)|GRCh38,,,ENSG00000123080,,cyclin dependent kinase inhibitor 2C,,
1067,1067,,dbSNP:rs3879293,rs3879293 mutation in MDM2 proto-oncogene (MDM2),presence of,risk_biomarker,tissue (UN:0000479),93805-0,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135679/HP_0001787,UPKB:Q00987 (MDM2 amplification)|GRCh38,3382.0,,ENSG00000135679,,MDM2 proto-oncogene,,Tiss
1068,1068,,dbSNP:rs13232767,rs13232767 mutation in enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2),presence of,risk_biomarker,blood (UN:0000178),96964-2,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000106462/HP_0001787,"UPKB:Q15910 (Y641,A677)|GRCh38 ",60058.0,,ENSG00000106462,,enhancer of zeste 2 polycomb repressive complex 2 subunit,"Y641,A677",Bld/Tiss
1069,1069,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 oncogenic mutation)|GRCh38,3284.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
1070,1070,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (E17K)|GRCh38 ,,,ENSG00000142208,,AKT serine/threonine kinase 1,E17K,Bld/Tiss
1071,1071,,dbSNP:rs182197129,rs182197129 mutation in cyclin D1 (CCND1),presence of,risk_biomarker,blood (UN:0000178),21744-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110092/HP_0001787,UPKB:P24385 (CCND1 amplification)|GRCh38,8923.0,,ENSG00000110092,,cyclin D1,,Bld/Tiss
1072,1072,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET fusion)|GRCh38,3910.0,,ENSG00000165731,,ret proto-oncogene,,Bld/Tiss
1073,1073,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,11934.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1074,1074,,dbSNP:rs1736215,rs1736215 mutation in folliculin (FLCN),presence of,risk_biomarker,blood (UN:0000178),57963-1,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000154803/HP_0001787,UPKB:Q8NFG4 (FLCN oncogenic mutation)|GRCh38,4451.0,,ENSG00000154803,,folliculin,,Bld/Tiss
1075,1075,,dbSNP:rs9873179,"rs9873179 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB)",presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000051382/HP_0001787,UPKB:P42338 (D1067Y)|GRCh38 ,3458.0,,ENSG00000051382,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",D1067Y,
1076,1076,,dbSNP:rs744617,rs744617 mutation in PML nuclear body scaffold (PML-RARA),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140464/HP_0001787,UPKB:P29590 (PML-RARA fusion)|GRCh38,9119.0,,ENSG00000140464,,PML nuclear body scaffold,,
1077,1077,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1078,1078,,dbSNP:rs73047773,"rs73047773 mutation in ERCC excision repair 1, endonuclease non-catalytic subunit (ERCC1)",presence of,risk_biomarker,tissue (UN:0000479),69572-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012061/HP_0001787,UPKB:P07992 (ERCC1 deletion)|GRCh38,3905.0,,ENSG00000012061,,"ERCC excision repair 1, endonuclease non-catalytic subunit",,Tiss
1079,1079,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1-BCR)",presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,UPKB:P00519 (ABL1-BCR fusion)|GRCh38,9952.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase",,
1080,1080,,dbSNP:Q9HC73,Q9HC73 mutation in cytokine receptor like factor 2 (CRLF2),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000205755/HP_0001787,UPKB:Q9HC73 (CRLF2 fusion)|GRCh38,9952.0,,ENSG00000205755,,cytokine receptor like factor 2,,
1081,1081,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,"UPKB:P04626 (P780GSP),inframe insertion (781GSP),inframe insertion (A775YVMA),inframe insertion (G776YVMA) (inframe_insertion:775-881)|GRCh38 ",,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,"P780GSP),inframe insertion (781GSP),inframe insertion (A775YVMA),inframe insertion (G776YVMA) (inframe_insertion:775-881",Tiss
1082,1082,,dbSNP:rs4456287,rs4456287 mutation in lysine methyltransferase 2A (MLL),presence of,risk_biomarker,blood (UN:0000178),35454-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118058/HP_0001787,UPKB:Q03164 (MLL fusion)|GRCh38,9119.0,,ENSG00000118058,,lysine methyltransferase 2A,,Bld/Tiss
1083,1083,,dbSNP:rs10878984,rs10878984 mutation in fibroblast growth factor receptor substrate 2 (FRS2),presence of,risk_biomarker,,,liposarcoma (DOID:3382),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000166225/HP_0001787,UPKB:Q8WU20 (FRS2 amplification)|GRCh38,3382.0,,ENSG00000166225,,fibroblast growth factor receptor substrate 2,,
1084,1084,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,11934.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1085,1085,,dbSNP:rs10749415,rs10749415 mutation in fibroblast growth factor receptor 2 (FGFR2),presence of,risk_biomarker,blood (UN:0000178),21674-7,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000066468/HP_0001787,"UPKB:P21802 (V565I,M536I,M538I,I548V,N550,E566G,L618M,K660E)|GRCh38 ",2871.0,,ENSG00000066468,,fibroblast growth factor receptor 2,"V565I,M536I,M538I,I548V,N550,E566G,L618M,K660E",Bld/Tiss
1086,1086,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,50861.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1087,1087,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1088,1088,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,50861.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1089,1089,,dbSNP:rs9813107,rs9813107 mutation in catenin beta 1 (CTNNB1),presence of,risk_biomarker,blood (UN:0000178),21659-8,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168036/HP_0001787,"UPKB:P35222 (H36Y,S37C,S37Y,D32V)|GRCh38 ",2871.0,,ENSG00000168036,,catenin beta 1,"H36Y,S37C,S37Y,D32V",Bld/Tiss
1090,1090,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,cervical carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1091,1091,,dbSNP:rs987106,rs987106 mutation in interleukin 7 receptor (IL7R),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168685/HP_0001787,UPKB:P16871 (S185C)|GRCh38 ,9952.0,,ENSG00000168685,,interleukin 7 receptor,S185C,
1092,1092,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 oncogenic mutation)|GRCh38,60058.0,,ENSG00000105810,,cyclin dependent kinase 6,,
1093,1093,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (Y553N)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",Y553N,Bld/Tiss
1094,1094,,dbSNP:rs530311131,rs530311131 mutation in von Hippel-Lindau tumor suppressor (VHL),presence of,risk_biomarker,blood (UN:0000178),34502-5,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134086/HP_0001787,UPKB:P40337 (VHL oncogenic mutation)|GRCh38,4451.0,,ENSG00000134086,,von Hippel-Lindau tumor suppressor,,Bld/Tiss
1095,1095,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (ROS1 fusion)|GRCh38,3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",,
1096,1096,,dbSNP:rs340797,"rs340797 mutation in MYCN proto-oncogene, bHLH transcription factor (MYCN)",presence of,risk_biomarker,blood (UN:0000178),93796-1,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134323/HP_0001787,UPKB:P04198 (MYCN amplification)|GRCh38,50902.0,,ENSG00000134323,,"MYCN proto-oncogene, bHLH transcription factor",,Bld/Tiss
1097,1097,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000091831,inframe_insertion:775-881,estrogen receptor 1,inframe_insertion:775-881,Tiss
1098,1098,,dbSNP:rs67009183,rs67009183 mutation in cyclin D2 (CCND2),presence of,risk_biomarker,,,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118971/HP_0001787,UPKB:P30279 (CCND2 amplification)|GRCh38,3905.0,,ENSG00000118971,,cyclin D2,,
1099,1099,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (N676)|GRCh38 ,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,N676,Bld/Tiss
1100,1100,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1101,1101,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (D1644A)|GRCh38 ,11934.0,,ENSG00000196712,,neurofibromin 1,D1644A,Bld/Tiss
1102,1102,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 oncogenic mutation)|GRCh38,,,ENSG00000163930,,BRCA1 associated protein 1,,
1103,1103,,dbSNP:rs107155,rs107155 mutation in G protein subunit alpha 11 (GNA11),presence of,risk_biomarker,blood (UN:0000178),100020-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000088256/HP_0001787,"UPKB:P29992 (Q209L,Q209P)|GRCh38 ",8923.0,,ENSG00000088256,,G protein subunit alpha 11,"Q209L,Q209P",Bld/Tiss
1104,1104,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (NF1)",presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (NF1 oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1105,1105,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,"UPKB:P07949 (C634W,M918T)|GRCh38 ",,,ENSG00000165731,,ret proto-oncogene,"C634W,M918T",Bld/Tiss
1106,1106,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
1107,1107,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (V559I,H697Y,T670,V654A,A829P,D816,N822,Y823D)|GRCh38 ",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","V559I,H697Y,T670,V654A,A829P,D816,N822,Y823D",Bld/Tiss
1108,1108,,dbSNP:rs9813107,rs9813107 mutation in catenin beta 1 (CTNNB1),presence of,risk_biomarker,blood (UN:0000178),21659-8,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000168036/HP_0001787,UPKB:P35222 (CTNNB1 oncogenic mutation)|GRCh38,50861.0,,ENSG00000168036,,catenin beta 1,,Bld/Tiss
1109,1109,,dbSNP:rs34231037,rs34231037 mutation in kinase insert domain receptor (KDR),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000128052/HP_0001787,UPKB:P35968 (A1065T)|GRCh38 ,,,ENSG00000128052,,kinase insert domain receptor,A1065T,
1110,1110,,dbSNP:rs68189791,rs68189791 mutation in neuregulin 1 (NRG1),presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157168/HP_0001787,UPKB:Q02297 (NRG1 fusion)|GRCh38,3910.0,,ENSG00000157168,,neuregulin 1,,
1111,1111,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1112,1112,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
1113,1113,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1114,1114,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1115,1115,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (N676)|GRCh38 ,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,N676,Bld/Tiss
1116,1116,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET fusion)|GRCh38,3910.0,,ENSG00000165731,,ret proto-oncogene,,Bld/Tiss
1117,1117,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
1118,1118,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,hyper eosinophilic advanced snydrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
1119,1119,,dbSNP:rs2298650,rs2298650 mutation in Cbl proto-oncogene (CBL),presence of,risk_biomarker,,,myelodisplasic proliferative syndrome,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110395/HP_0001787,"UPKB:P22681 (Y371H,C384R)|GRCh38 ",,,ENSG00000110395,,Cbl proto-oncogene,"Y371H,C384R",
1120,1120,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,UPKB:P51580 (TPMT splice acceptor variant)|GRCh38,,,ENSG00000137364,,thiopurine S-methyltransferase,,Bld
1121,1121,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1122,1122,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,adenoid cystic carcinoma (DOID:0080202),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,"UPKB:P46531 (2245-2536),splice acceptor variant (2245-2536),stop gained (2245-2536),stop lost (2245-2536),frameshift variant (2245-2536)|GRCh38 ",80202.0,,ENSG00000148400,,notch receptor 1,"2245-2536),splice acceptor variant (2245-2536),stop gained (2245-2536),stop lost (2245-2536),frameshift variant (2245-2536",Bld/Tiss
1123,1123,,dbSNP:rs12096443,rs12096443 mutation in cyclin dependent kinase inhibitor 2C (CDKN2C),presence of,risk_biomarker,,,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000123080/HP_0001787,UPKB:P42773 (CDKN2C oncogenic mutation)|GRCh38,,,ENSG00000123080,,cyclin dependent kinase inhibitor 2C,,
1124,1124,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (577-579)|GRCh38 ,3284.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",577-579,Bld/Tiss
1125,1125,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1126,1126,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,8923.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1127,1127,,dbSNP:rs116434758,rs116434758 mutation in G protein subunit alpha q (GNAQ),presence of,risk_biomarker,blood (UN:0000178),100021-5,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000156052/HP_0001787,UPKB:P50148 (Q209)|GRCh38 ,8923.0,,ENSG00000156052,,G protein subunit alpha q,Q209,Bld/Tiss
1128,1128,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,osteosarcoma (DOID:3347),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,3347.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1129,1129,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,neuroendocrine tumor (DOID:169),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,169.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1130,1130,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1131,1131,,dbSNP:rs4148325,rs4148325 mutation in UDP glucuronosyltransferase family 1 member A1 (UGT1A1),presence of,risk_biomarker,blood (UN:0000178),34509-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000241635/HP_0001787,UPKB:P22309 (UGT1A1 biallelic inactivation)|GRCh38,,,ENSG00000241635,,UDP glucuronosyltransferase family 1 member A1,,Bld/Tiss
1132,1132,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,cervical squamous cell carcinoma (DOID:3744),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,3744.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
1133,1133,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,angiosarcoma (DOID:0001816),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,UPKB:P42345 (I1973F)|GRCh38 ,1816.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,I1973F,
1134,1134,,dbSNP:rs2584124,rs2584124 mutation in neurotrophic receptor tyrosine kinase 3 (NTRK3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140538/HP_0001787,UPKB:Q16288 (G623R)|GRCh38 ,,,ENSG00000140538,,neurotrophic receptor tyrosine kinase 3,G623R,
1135,1135,,dbSNP:rs5757592,rs5757592 mutation in platelet derived growth factor subunit B (PDGFB-COL1A1),presence of,risk_biomarker,,,dermatofibrosarcoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000100311/HP_0001787,UPKB:P01127 (PDGFB-COL1A1 fusion)|GRCh38,,,ENSG00000100311,,platelet derived growth factor subunit B,,
1136,1136,,dbSNP:rs2497938,rs2497938 mutation in androgen receptor (AR),presence of,risk_biomarker,blood (UN:0000178),21754-7,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169083/HP_0001787,UPKB:P10275 (F877L) + AR (T878A)|GRCh38 ,2526.0,,ENSG00000169083,,androgen receptor,F877L) + AR (T878A,Bld/Tiss
1137,1137,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1138,1138,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN biallelic inactivation)|GRCh38,50861.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1139,1139,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1140,1140,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1141,1141,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,"UPKB:P07949 (C634W,M918T)|GRCh38 ",,,ENSG00000165731,,ret proto-oncogene,"C634W,M918T",Bld/Tiss
1142,1142,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1143,1143,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,50861.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1144,1144,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (IDH1 oncogenic mutation)|GRCh38,9119.0,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,,Bld/Tiss
1145,1145,,dbSNP:rs12093576,rs12093576 mutation in AKT serine/threonine kinase 3 (AKT3),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000117020/HP_0001787,UPKB:Q9Y243 (AKT3 fusion)|GRCh38,3458.0,,ENSG00000117020,,AKT serine/threonine kinase 3,,
1146,1146,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,thyroid carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1147,1147,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation)|GRCh38,,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
1148,1148,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,2871.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
1149,1149,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
1150,1150,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT wildtype)|GRCh38,,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1151,1151,,dbSNP:rs34969716,rs34969716 mutation in thiopurine S-methyltransferase (TPMT),presence of,risk_biomarker,blood (UN:0000178),100663-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000137364/HP_0001787,"UPKB:P51580 (A80P,Y240C,A154T,A167G)|GRCh38 ",,,ENSG00000137364,,thiopurine S-methyltransferase,"A80P,Y240C,A154T,A167G",Bld
1152,1152,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1153,1153,,dbSNP:rs42033,rs42033 mutation in cyclin dependent kinase 6 (CDK6),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105810/HP_0001787,UPKB:Q00534 (CDK6 amplification)|GRCh38,,,ENSG00000105810,,cyclin dependent kinase 6,,
1154,1154,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1155,1155,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1156,1156,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
1157,1157,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1158,1158,,dbSNP:rs74634457,rs74634457 mutation in mitogen-activated protein kinase kinase 1 (MAP2K1),presence of,risk_biomarker,blood (UN:0000178),60495-9,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000169032/HP_0001787,UPKB:Q02750 (Q56P)|GRCh38 ,,,ENSG00000169032,,mitogen-activated protein kinase kinase 1,Q56P,Bld/Tiss
1159,1159,,dbSNP:rs17758695,rs17758695 mutation in BCL2 apoptosis regulator (BCL2),presence of,risk_biomarker,blood (UN:0000178),21095-5,lymphoma (DOID:0060058),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171791/HP_0001787,UPKB:P10415 (BCL2 amplification)|GRCh38,60058.0,,ENSG00000171791,,BCL2 apoptosis regulator,,Bld/Tiss
1160,1160,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,"UPKB:P08922 (S1986Y,S1986F)|GRCh38 ",3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase","S1986Y,S1986F",
1161,1161,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,4001.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
1162,1162,,dbSNP:rs76806311,rs76806311 mutation in fms related receptor tyrosine kinase 1 (FLT1),presence of,risk_biomarker,,,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000102755/HP_0001787,UPKB:P17948 (FLT1 overexpression)|GRCh38,4451.0,,ENSG00000102755,,fms related receptor tyrosine kinase 1,,
1163,1163,,dbSNP:rs200672841,rs200672841 mutation in U2 small nuclear RNA auxiliary factor 1 (U2AF1),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000160201/HP_0001787,UPKB:Q01081 (U2AF1 oncogenic mutation)|GRCh38,,,ENSG00000160201,,U2 small nuclear RNA auxiliary factor 1,,
1164,1164,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3-ITD),presence of,risk_biomarker,,,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (FLT3-ITD)|GRCh38,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,,
1165,1165,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (D194E)|GRCh38 ,4905.0,,ENSG00000118046,,serine/threonine kinase 11,D194E,Bld/Tiss
1166,1166,,dbSNP:rs191425998,rs191425998 mutation in F-box and WD repeat domain containing 7 (FBXW7),presence of,risk_biomarker,blood (UN:0000178),100028-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000109670/HP_0001787,UPKB:Q969H0 (FBXW7 oncogenic mutation)|GRCh38,,,ENSG00000109670,,F-box and WD repeat domain containing 7,,Bld/Tiss
1167,1167,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (G466V)|GRCh38 ,3910.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",G466V,Bld/Tiss
1168,1168,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1169,1169,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,"UPKB:P15056 (L485),inframe deletion (P490)|GRCh38 ",,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase","L485),inframe deletion (P490",Bld/Tiss
1170,1170,,dbSNP:rs705702,rs705702 mutation in erb-b2 receptor tyrosine kinase 3 (ERBB3),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000065361/HP_0001787,"UPKB:P21860 (P262H,G284R,Q809R)|GRCh38 ",,,ENSG00000065361,,erb-b2 receptor tyrosine kinase 3,"P262H,G284R,Q809R",
1171,1171,,dbSNP:rs2240775,rs2240775 mutation in serine and arginine rich splicing factor 2 (SRSF2),presence of,risk_biomarker,blood (UN:0000178),100025-6,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000161547/HP_0001787,UPKB:Q01130 (SRSF2 oncogenic mutation)|GRCh38,9119.0,,ENSG00000161547,,serine and arginine rich splicing factor 2,,Bld/Tiss
1172,1172,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,malignant peripheral nerve sheat tumor,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1173,1173,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1174,1174,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,50861.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1175,1175,,dbSNP:rs2494748,rs2494748 mutation in AKT serine/threonine kinase 1 (AKT1),presence of,risk_biomarker,blood (UN:0000178),42777-3,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000142208/HP_0001787,UPKB:P31749 (E17K)|GRCh38 ,2871.0,,ENSG00000142208,,AKT serine/threonine kinase 1,E17K,Bld/Tiss
1176,1176,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (788-828,829-860,550-592)|GRCh38 ",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","788-828,829-860,550-592",Bld/Tiss
1177,1177,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,osteosarcoma (DOID:3347),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,3347.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1178,1178,,dbSNP:rs2306390,rs2306390 mutation in cyclin dependent kinase 4 (CDK4),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135446/HP_0001787,UPKB:P11802 (CDK4 amplification)|GRCh38,,,ENSG00000135446,,cyclin dependent kinase 4,,
1179,1179,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1180,1180,,dbSNP:rs7853926,rs7853926 mutation in TSC complex subunit 1 (TSC1),presence of,risk_biomarker,blood (UN:0000178),48979-9,giant cell astrocytoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165699/HP_0001787,UPKB:Q92574 (TSC1 oncogenic mutation)|GRCh38,,,ENSG00000165699,,TSC complex subunit 1,,Bld/Tiss
1181,1181,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,"UPKB:P04637 (R248Q,R175H)|GRCh38 ",,,ENSG00000141510,,tumor protein p53,"R248Q,R175H",Bld/Tiss
1182,1182,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1183,1183,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (S720) (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,S720) (inframe_insertion:729-761,Bld/Tiss
1184,1184,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,9952.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
1185,1185,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1186,1186,,dbSNP:Q06187,Q06187 mutation in Bruton tyrosine kinase (BTK),presence of,risk_biomarker,blood (UN:0000178),35295-5,chronic lymphocytic leukemia (DOID:1040),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000010671/HP_0001787,UPKB:Q06187 (C481S)|GRCh38 ,1040.0,,ENSG00000010671,,Bruton tyrosine kinase,C481S,Bld/Tiss
1187,1187,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L747),inframe insertion (P753PS) (inframe_insertion:729-761)|GRCh38 ",11934.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L747),inframe insertion (P753PS) (inframe_insertion:729-761",Bld/Tiss
1188,1188,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (NF2),presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (NF2 deletion + EGFR oncogenic mutation)|GRCh38,3905.0,,ENSG00000146648,,epidermal growth factor receptor,,Amnio fld
1189,1189,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,"UPKB:P00533 (L858R,L861,G719,S768I) (inframe_insertion:729-761)|GRCh38 ",3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,"L858R,L861,G719,S768I) (inframe_insertion:729-761",Bld/Tiss
1190,1190,,dbSNP:rs1871859,rs1871859 mutation in estrogen receptor 1 (ESR1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000091831/HP_0001787,UPKB:P03372 (Y537S)|GRCh38 ,3458.0,,ENSG00000091831,,estrogen receptor 1,Y537S,
1191,1191,,dbSNP:rs8187929,rs8187929 mutation in annexin A1 (ARID1A),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000135046/HP_0001787,UPKB:P04083 (ARID1A amplification + ANXA1 overexpression)|GRCh38,3458.0,,ENSG00000135046,,annexin A1,,
1192,1192,,dbSNP:rs9568025,rs9568025 mutation in RB transcriptional corepressor 1 (RB1),presence of,risk_biomarker,blood (UN:0000178),21731-5,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139687/HP_0001787,UPKB:P06400 (RB1 oncogenic mutation)|GRCh38,4007.0,,ENSG00000139687,,RB transcriptional corepressor 1,,Bld/Tiss
1193,1193,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1194,1194,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1195,1195,,dbSNP:rs4740360,"rs4740360 mutation in ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1)",presence of,risk_biomarker,blood (UN:0000178),95550-0,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000097007/HP_0001787,"UPKB:P00519 (F359V,F359C,F359I,Y253H,E255K,E255V)|GRCh38 ",8552.0,,ENSG00000097007,,"ABL proto-oncogene 1, non-receptor tyrosine kinase","F359V,F359C,F359I,Y253H,E255K,E255V",Bld/Bone mar
1196,1196,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,"UPKB:P42345 (L1460P,S2215Y,R2505P)|GRCh38 ",,,ENSG00000198793,,mechanistic target of rapamycin kinase,"L1460P,S2215Y,R2505P",
1197,1197,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1198,1198,,dbSNP:rs145922731,rs145922731 mutation in FA complementation group C (FANCC),presence of,risk_biomarker,blood (UN:0000178),32639-7,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000158169/HP_0001787,UPKB:Q00597 (FANCC deletion)|GRCh38,4007.0,,ENSG00000158169,,FA complementation group C,,Bld/Tiss
1199,1199,,dbSNP:rs117916865,rs117916865 mutation in lysine methyltransferase 2D (MLL2),presence of,risk_biomarker,,,squamous cell lung carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000167548/HP_0001787,UPKB:O14686 (MLL2 oncogenic mutation)|GRCh38,,,ENSG00000167548,,lysine methyltransferase 2D,,
1200,1200,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (V600E)|GRCh38 ,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",V600E,Bld/Tiss
1201,1201,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1202,1202,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1203,1203,,dbSNP:rs553084547,"rs553084547 mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)",presence of,risk_biomarker,blood (UN:0000178),60033-8,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000121879/HP_0001787,UPKB:P42336 (PIK3CA oncogenic mutation)|GRCh38,50861.0,,ENSG00000121879,,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",,Bld/Tiss
1204,1204,,dbSNP:rs71487219,"rs71487219 mutation in HRas proto-oncogene, GTPase (HRAS)",presence of,risk_biomarker,blood (UN:0000178),21698-6,cervical squamous cell carcinoma (DOID:3744),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000174775/HP_0001787,UPKB:P01112 (HRAS oncogenic mutation)|GRCh38,3744.0,,ENSG00000174775,,"HRas proto-oncogene, GTPase",,Bld/Tiss
1205,1205,,,,presence of,risk_biomarker,blood (UN:0000178),100761-6,pancreatic carcinoma (DOID:4905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000083093/HP_0001787,UPKB:Q86YC2 (PALB2 oncogenic mutation)|GRCh38,4905.0,,ENSG00000083093,,partner and localizer of BRCA2,,Bld/Tiss
1206,1206,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,4001.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1207,1207,,dbSNP:rs144941122,rs144941122 mutation in 3-phosphoinositide dependent protein kinase 1 (PDPK1),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000140992/HP_0001787,UPKB:O15530 (PDPK1 amplification)|GRCh38,3458.0,,ENSG00000140992,,3-phosphoinositide dependent protein kinase 1,,
1208,1208,,dbSNP:rs530311131,rs530311131 mutation in von Hippel-Lindau tumor suppressor (VHL),presence of,risk_biomarker,blood (UN:0000178),34502-5,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134086/HP_0001787,UPKB:P40337 (VHL oncogenic mutation)|GRCh38,4451.0,,ENSG00000134086,,von Hippel-Lindau tumor suppressor,,Bld/Tiss
1209,1209,,dbSNP:rs28841391,rs28841391 mutation in serine/threonine kinase 11 (STK11),presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000118046/HP_0001787,UPKB:Q15831 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000118046,,serine/threonine kinase 11,,Bld/Tiss
1210,1210,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,2871.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1211,1211,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1212,1212,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,5517.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1213,1213,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1214,1214,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (KIT mutation in exon 17 or 18)|GRCh38,8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1215,1215,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA wildtype)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
1216,1216,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (550-592,627-664,788-828,829-860)|GRCh38 ",8923.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","550-592,627-664,788-828,829-860",Bld/Tiss
1217,1217,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (D842V)|GRCh38 ,,,ENSG00000134853,,platelet derived growth factor receptor alpha,D842V,Bld/Tiss
1218,1218,,dbSNP:rs3731246,rs3731246 mutation in cyclin dependent kinase inhibitor 2B (CDKN2B),presence of,risk_biomarker,blood (UN:0000178),21615-0,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147883/HP_0001787,UPKB:P42772 (CDKN2B deletion)|GRCh38,,,ENSG00000147883,,cyclin dependent kinase inhibitor 2B,,Bld/Tiss
1219,1219,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1220,1220,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (416-422),inframe insertion (416-422)|GRCh38 ",9119.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","416-422),inframe insertion (416-422",Bld/Tiss
1221,1221,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 fusion)|GRCh38,3458.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
1222,1222,,dbSNP:P10398,"P10398 mutation in A-Raf proto-oncogene, serine/threonine kinase (ARAF)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000078061/HP_0001787,UPKB:P10398 (S214C)|GRCh38 ,3910.0,,ENSG00000078061,,"A-Raf proto-oncogene, serine/threonine kinase",S214C,
1223,1223,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,"UPKB:P08581 (V1110I,H1112R,M1268T,R988C,T1010I)|GRCh38 ",,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase","V1110I,H1112R,M1268T,R988C,T1010I",Bld/Tiss
1224,1224,,dbSNP:rs6729895,rs6729895 mutation in isocitrate dehydrogenase (NADP(+)) 1 (IDH1),presence of,risk_biomarker,blood (UN:0000178),100022-3,cholangiocarcinoma (DOID:4947),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000138413/HP_0001787,UPKB:O75874 (IDH1 oncogenic mutation)|GRCh38,4947.0,,ENSG00000138413,,isocitrate dehydrogenase (NADP(+)) 1,,Bld/Tiss
1225,1225,,dbSNP:rs7163762,rs7163762 mutation in isocitrate dehydrogenase (NADP(+)) 2 (IDH2),presence of,risk_biomarker,blood (UN:0000178),100023-1,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000182054/HP_0001787,UPKB:P48735 (IDH2 oncogenic mutation)|GRCh38,9119.0,,ENSG00000182054,,isocitrate dehydrogenase (NADP(+)) 2,,Bld/Tiss
1226,1226,,dbSNP:rs72922276,rs72922276 mutation in Janus kinase 1 (JAK1),presence of,risk_biomarker,,,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000162434/HP_0001787,UPKB:P23458 (JAK1 oncogenic mutation)|GRCh38,50861.0,,ENSG00000162434,,Janus kinase 1,,
1227,1227,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1228,1228,,dbSNP:rs1495099,rs1495099 mutation in cyclin dependent kinase 12 (CDK12),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000167258/HP_0001787,UPKB:Q9NYV4 (CDK12 amplification)|GRCh38,4001.0,,ENSG00000167258,,cyclin dependent kinase 12,,
1229,1229,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (C1156Y)|GRCh38 ,3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,C1156Y,Bld/Tiss
1230,1230,,dbSNP:rs6784615,rs6784615 mutation in BRCA1 associated protein 1 (BAP1),presence of,risk_biomarker,,,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000163930/HP_0001787,UPKB:Q92560 (BAP1 deletion)|GRCh38,8923.0,,ENSG00000163930,,BRCA1 associated protein 1,,
1231,1231,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,"UPKB:Q9UM73 (L1196M,S1206Y,G1269A,I1171T)|GRCh38 ",3910.0,,ENSG00000171094,,ALK receptor tyrosine kinase,"L1196M,S1206Y,G1269A,I1171T",Bld/Tiss
1232,1232,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1233,1233,,dbSNP:rs4570704,rs4570704 mutation in BRCA2 DNA repair associated (BRCA2),presence of,risk_biomarker,blood (UN:0000178),21640-8,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000139618/HP_0001787,UPKB:P51587 (BRCA2 oncogenic mutation)|GRCh38,8923.0,,ENSG00000139618,,BRCA2 DNA repair associated,,Bld/Tiss
1234,1234,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3458.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1235,1235,,dbSNP:rs663474,"rs663474 mutation in ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)",presence of,risk_biomarker,,,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000047936/HP_0001787,UPKB:P08922 (ROS1 fusion)|GRCh38,3910.0,,ENSG00000047936,,"ROS proto-oncogene 1, receptor tyrosine kinase",,
1236,1236,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1237,1237,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,leukemia (DOID:1240),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,1240.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1238,1238,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (K753E) (inframe_insertion:775-881)|GRCh38 ,3458.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,K753E) (inframe_insertion:775-881,Tiss
1239,1239,,dbSNP:rs4899037,rs4899037 mutation in protein kinase C eta (PRKCH),presence of,risk_biomarker,,,chronic myeloid leukemia (DOID:8552),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000027075/HP_0001787,UPKB:P24723 (PRKCH amplification + ABL1-BCR fusion)|GRCh38,8552.0,,ENSG00000027075,,protein kinase C eta,,
1240,1240,,dbSNP:rs10844639,rs10844639 mutation in CD69 molecule (CD69),presence of,risk_biomarker,blood (UN:0000178),5522-8,chronic lymphocytic leukemia (DOID:1040),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000110848/HP_0001787,UPKB:Q07108 (CD69 undexpression)|GRCh38,1040.0,,ENSG00000110848,,CD69 molecule,,WBC
1241,1241,,dbSNP:rs72692916,rs72692916 mutation in protein tyrosine phosphatase receptor type D (PTPRD),presence of,risk_biomarker,,,sarcoma (DOID:1115),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000153707/HP_0001787,UPKB:P23468 (PTPRD oncogenic mutation)|GRCh38,1115.0,,ENSG00000153707,,protein tyrosine phosphatase receptor type D,,
1242,1242,,dbSNP:rs3124592,rs3124592 mutation in notch receptor 1 (NOTCH1),presence of,risk_biomarker,blood (UN:0000178),99126-5,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000148400/HP_0001787,UPKB:P46531 (NOTCH1 activating mutation in Cterm-PEST domain)|GRCh38,3458.0,,ENSG00000148400,,notch receptor 1,,Bld/Tiss
1243,1243,,dbSNP:rs35221880,"rs35221880 mutation in DNA polymerase epsilon, catalytic subunit (POLE)",presence of,risk_biomarker,,,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000177084/HP_0001787,UPKB:Q07864 (268-471)|GRCh38 ,2871.0,,ENSG00000177084,,"DNA polymerase epsilon, catalytic subunit",268-471,
1244,1244,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN deletion)|GRCh38,4001.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1245,1245,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1246,1246,,dbSNP:rs200368423,rs200368423 mutation in notch receptor 2 (NOTCH2),presence of,risk_biomarker,,,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134250/HP_0001787,UPKB:Q04721 (NOTCH2 fusion)|GRCh38,3458.0,,ENSG00000134250,,notch receptor 2,,
1247,1247,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,"UPKB:P10721 (627-664,664-714,449-514)|GRCh38 ",,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase","627-664,664-714,449-514",Bld/Tiss
1248,1248,,dbSNP:rs116434758,rs116434758 mutation in G protein subunit alpha q (GNAQ),presence of,risk_biomarker,blood (UN:0000178),100021-5,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000156052/HP_0001787,UPKB:P50148 (Q209)|GRCh38 ,8923.0,,ENSG00000156052,,G protein subunit alpha q,Q209,Bld/Tiss
1249,1249,,dbSNP:rs73047773,"rs73047773 mutation in ERCC excision repair 1, endonuclease non-catalytic subunit (ERCC1)",presence of,risk_biomarker,tissue (UN:0000479),69572-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012061/HP_0001787,UPKB:P07992 (ERCC1 oncogenic mutation)|GRCh38,3905.0,,ENSG00000012061,,"ERCC excision repair 1, endonuclease non-catalytic subunit",,Tiss
1250,1250,,dbSNP:rs13166875,rs13166875 mutation in RPTOR independent companion of MTOR complex 2 (RICTOR),presence of,risk_biomarker,,,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000164327/HP_0001787,UPKB:Q6R327 (RICTOR amplification)|GRCh38,3905.0,,ENSG00000164327,,RPTOR independent companion of MTOR complex 2,,
1251,1251,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,renal carcinoma (DOID:4451),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,4451.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1252,1252,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,hematologic malignancies,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1253,1253,,dbSNP:rs460976,rs460976 mutation in transmembrane serine protease 2 (TMPRSS2),presence of,risk_biomarker,,,prostate adenocarcinoma (DOID:2526),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000184012/HP_0001787,UPKB:O15393 (TMPRSS2 fusion)|GRCh38,2526.0,,ENSG00000184012,,transmembrane serine protease 2,,
1254,1254,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,meningioma (DOID:3565),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 oncogenic mutation)|GRCh38,3565.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1255,1255,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,hepatic carcinoma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1256,1256,,dbSNP:rs7715167,rs7715167 mutation in nucleophosmin 1 (NPM1),presence of,risk_biomarker,blood (UN:0000178),54448-6,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000181163/HP_0001787,UPKB:P06748 (NPM1 oncogenic mutation)|GRCh38,9119.0,,ENSG00000181163,,nucleophosmin 1,,Bld/Tiss
1257,1257,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,3905.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1258,1258,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,gastric carcinoma (DOID:5517),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification + ERBB2 amplification)|GRCh38,5517.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1259,1259,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (BRAF),presence of,risk_biomarker,blood (UN:0000178),53844-7,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (G469A)|GRCh38 ,3910.0,,ENSG00000146648,,epidermal growth factor receptor,G469A,Bld/Tiss
1260,1260,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (E690K) (inframe_insertion:729-761)|GRCh38 ,2871.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,E690K) (inframe_insertion:729-761,Bld/Tiss
1261,1261,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1262,1262,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation + ERBB2 amplification)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1263,1263,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (V600E)|GRCh38 ,4001.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",V600E,Bld/Tiss
1264,1264,,dbSNP:rs73159014,"rs73159014 mutation in NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor (NF2)",presence of,risk_biomarker,amniotic fluid (UN:0000173),45332-4,schwannoma (DOID:3192),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000186575/HP_0001787,UPKB:P35240 (NF2 deletion)|GRCh38,3192.0,,ENSG00000186575,,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",,Amnio fld
1265,1265,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,non-small cell lung cancer (DOID:3908),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (T790M) (inframe_insertion:729-761)|GRCh38 ,3908.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,T790M) (inframe_insertion:729-761,Bld/Tiss
1266,1266,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,neurofibroma (DOID:962),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,962.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1267,1267,,dbSNP:rs218265,"rs218265 mutation in KIT proto-oncogene, receptor tyrosine kinase (KIT)",presence of,risk_biomarker,blood (UN:0000178),55201-8,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157404/HP_0001787,UPKB:P10721 (D816)|GRCh38 ,9952.0,,ENSG00000157404,,"KIT proto-oncogene, receptor tyrosine kinase",D816,Bld/Tiss
1268,1268,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,leukemia (DOID:1240),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 deletion)|GRCh38,1240.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1269,1269,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (30-336) (inframe_insertion:729-761)|GRCh38 ,,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,30-336) (inframe_insertion:729-761,Bld/Tiss
1270,1270,,dbSNP:rs1447523,rs1447523 mutation in ALK receptor tyrosine kinase (ALK),presence of,risk_biomarker,blood (UN:0000178),100019-9,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171094/HP_0001787,UPKB:Q9UM73 (ALK fusion)|GRCh38,50861.0,,ENSG00000171094,,ALK receptor tyrosine kinase,,Bld/Tiss
1271,1271,,dbSNP:Q9HC73,Q9HC73 mutation in cytokine receptor like factor 2 (CRLF2),presence of,risk_biomarker,,,acute lymphoblastic leukemia (DOID:9952),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000205755/HP_0001787,UPKB:Q9HC73 (CRLF2 fusion)|GRCh38,9952.0,,ENSG00000205755,,cytokine receptor like factor 2,,
1272,1272,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (G13D)|GRCh38 ,50861.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",G13D,Bld/Tiss
1273,1273,,dbSNP:rs12144048,rs12144048 mutation in mechanistic target of rapamycin kinase (MTOR),presence of,risk_biomarker,,,bladder carcinoma (DOID:4007),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000198793/HP_0001787,"UPKB:P42345 (E2014K,E2419K,N1421D)|GRCh38 ",4007.0,,ENSG00000198793,,mechanistic target of rapamycin kinase,"E2014K,E2419K,N1421D",
1274,1274,,dbSNP:rs1799949,rs1799949 mutation in BRCA1 DNA repair associated (BRCA1),presence of,risk_biomarker,blood (UN:0000178),21636-6,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000012048/HP_0001787,UPKB:P38398 (BRCA1 oncogenic mutation)|GRCh38,3458.0,,ENSG00000012048,,BRCA1 DNA repair associated,,Bld/Tiss
1275,1275,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET amplification)|GRCh38,50861.0,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
1276,1276,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (NF1)",presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (NF1 deletion + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1277,1277,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,colorectal adenocarcinoma (DOID:0050861),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,50861.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1278,1278,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation)|GRCh38,,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1279,1279,,dbSNP:rs17022006,rs17022006 mutation in cereblon (CRBN),presence of,risk_biomarker,,,myeloma (DOID:9538),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000113851/HP_0001787,UPKB:Q96SW2 (CRBN oncogenic mutation)|GRCh38,9538.0,,ENSG00000113851,,cereblon,,
1280,1280,,dbSNP:rs6671984,"rs6671984 mutation in NRAS proto-oncogene, GTPase (NRAS)",presence of,risk_biomarker,blood (UN:0000178),21719-0,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000213281/HP_0001787,UPKB:P01111 (NRAS oncogenic mutation)|GRCh38,8923.0,,ENSG00000213281,,"NRAS proto-oncogene, GTPase",,Bld/Tiss
1281,1281,,dbSNP:rs2435355,rs2435355 mutation in ret proto-oncogene (RET),presence of,risk_biomarker,blood (UN:0000178),21733-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000165731/HP_0001787,UPKB:P07949 (RET fusion)|GRCh38,3910.0,,ENSG00000165731,,ret proto-oncogene,,Bld/Tiss
1282,1282,,dbSNP:rs1234219,rs1234219 mutation in phosphatase and tensin homolog (PTEN),presence of,risk_biomarker,blood (UN:0000178),47969-1,breast adenocarcinoma (DOID:3458),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000171862/HP_0001787,UPKB:P60484 (PTEN oncogenic mutation)|GRCh38,3458.0,,ENSG00000171862,,phosphatase and tensin homolog,,Bld/Tiss
1283,1283,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,"UPKB:P36888 (F691,D835,N676,Y842)|GRCh38 ",9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,"F691,D835,N676,Y842",Bld/Tiss
1284,1284,,dbSNP:rs56337234,rs56337234 mutation in fibroblast growth factor receptor 3 (FGFR3),presence of,risk_biomarker,blood (UN:0000178),21676-2,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000068078/HP_0001787,"UPKB:P22607 (S249C,G691R)|GRCh38 ",3910.0,,ENSG00000068078,,fibroblast growth factor receptor 3,"S249C,G691R",Bld/Tiss
1285,1285,,dbSNP:rs3829814,"rs3829814 mutation in B-Raf proto-oncogene, serine/threonine kinase (BRAF)",presence of,risk_biomarker,blood (UN:0000178),53844-7,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000157764/HP_0001787,UPKB:P15056 (BRAF fusion)|GRCh38,8923.0,,ENSG00000157764,,"B-Raf proto-oncogene, serine/threonine kinase",,Bld/Tiss
1286,1286,,dbSNP:rs7785013,rs7785013 mutation in epidermal growth factor receptor (EGFR),presence of,risk_biomarker,blood (UN:0000178),21665-5,lung carcinoma (DOID:3905),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000146648/HP_0001787,UPKB:P00533 (inframe_insertion:729-761)|GRCh38 ,3905.0,,ENSG00000146648,inframe_insertion:729-761,epidermal growth factor receptor,inframe_insertion:729-761,Bld/Tiss
1287,1287,,dbSNP:rs357564,rs357564 mutation in patched 1 (PTCH1),presence of,risk_biomarker,,,medulloblastoma (DOID:0050902),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000185920/HP_0001787,UPKB:Q13635 (PTCH1 oncogenic mutation)|GRCh38,50902.0,,ENSG00000185920,,patched 1,,
1288,1288,,dbSNP:rs881844,rs881844 mutation in erb-b2 receptor tyrosine kinase 2 (ERBB2),presence of,risk_biomarker,tissue (UN:0000479),31150-6,head and neck cancer (DOID:11934),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141736/HP_0001787,UPKB:P04626 (inframe_insertion:775-881)|GRCh38 ,11934.0,,ENSG00000141736,inframe_insertion:775-881,erb-b2 receptor tyrosine kinase 2,inframe_insertion:775-881,Tiss
1289,1289,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (KRAS)",presence of,risk_biomarker,blood (UN:0000178),21702-6,endometrial carcinoma (DOID:2871),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (KRAS oncogenic mutation)|GRCh38,2871.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1290,1290,,dbSNP:rs11734754,rs11734754 mutation in platelet derived growth factor receptor alpha (PDGFRA),presence of,risk_biomarker,blood (UN:0000178),55092-1,gastrointestinal stromal,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000134853/HP_0001787,UPKB:P16234 (PDGFRA wildtype)|GRCh38,,,ENSG00000134853,,platelet derived growth factor receptor alpha,,Bld/Tiss
1291,1291,,dbSNP:rs3837848,rs3837848 mutation in neurofibromin 1 (NF1),presence of,risk_biomarker,blood (UN:0000178),21717-4,cutaneous melanoma (DOID:8923),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000196712/HP_0001787,UPKB:P21359 (NF1 oncogenic mutation + BRAF oncogenic mutation)|GRCh38,8923.0,,ENSG00000196712,,neurofibromin 1,,Bld/Tiss
1292,1292,,dbSNP:rs61764367,"rs61764367 mutation in KRAS proto-oncogene, GTPase (STK11)",presence of,risk_biomarker,blood (UN:0000178),53795-1,lung adenocarcinoma (DOID:3910),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000133703/HP_0001787,UPKB:P01116 (STK11 oncogenic mutation + KRAS oncogenic mutation)|GRCh38,3910.0,,ENSG00000133703,,"KRAS proto-oncogene, GTPase",,Bld/Tiss
1293,1293,,dbSNP:rs55831773,rs55831773 mutation in tumor protein p53 (TP53),presence of,risk_biomarker,blood (UN:0000178),21739-8,thymic carcinoma (DOID:3284),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000141510/HP_0001787,UPKB:P04637 (TP53 deletion)|GRCh38,3284.0,,ENSG00000141510,,tumor protein p53,,Bld/Tiss
1294,1294,,dbSNP:rs3731246,rs3731246 mutation in cyclin dependent kinase inhibitor 2B (CDKN2B),presence of,risk_biomarker,blood (UN:0000178),21615-0,any cancer type,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000147883/HP_0001787,UPKB:P42772 (CDKN2B deletion)|GRCh38,,,ENSG00000147883,,cyclin dependent kinase inhibitor 2B,,Bld/Tiss
1295,1295,,dbSNP:rs76428106,rs76428106 mutation in fms related receptor tyrosine kinase 3 (FLT3),presence of,risk_biomarker,blood (UN:0000178),47958-4,acute myeloid leukemia (DOID:9119),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000122025/HP_0001787,UPKB:P36888 (D835)|GRCh38 ,9119.0,,ENSG00000122025,,fms related receptor tyrosine kinase 3,D835,Bld/Tiss
1296,1296,,dbSNP:rs1495099,rs1495099 mutation in cyclin dependent kinase 12 (CDK12),presence of,risk_biomarker,,,ovarian carcinoma (DOID:4001),gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000167258/HP_0001787,UPKB:Q9NYV4 (CDK12 oncogenic mutation)|GRCh38,4001.0,,ENSG00000167258,,cyclin dependent kinase 12,,
1297,1297,,dbSNP:rs38859,"rs38859 mutation in MET proto-oncogene, receptor tyrosine kinase (MET)",presence of,risk_biomarker,blood (UN:0000178),100026-4,glioma,gene,OpenTarget|https://platform.opentargets.org/evidence/ENSG00000105976/HP_0001787,UPKB:P08581 (MET fusion)|GRCh38,,,ENSG00000105976,,"MET proto-oncogene, receptor tyrosine kinase",,Bld/Tiss
